1. No category

CURRICULUM VITAE
JOHN T. SINNOTT, MD, FACP
Mailing Address:
Division of Infectious Disease &
International Medicine
1 Tampa General Circle
Tampa, Florida 33606
(813) 844.4174 Office
(813) 844.7605 Fax
[email protected]
www.instituteid.com
James Cullison Professor of Medicine
Associate Dean, USF Medicine International
Director, Division of Infectious Disease and International Medicine
Department of Internal Medicine, College of Medicine, University of South Florida
Co-Director, Signature Interdisciplinary Program in Allergy, Immunology and Infectious Disease
Education:
University of South Alabama College of Medicine, Mobile, Alabama, 1978, MD
University of South Florida, Tampa, Florida, 1973, Microbiology, MA
Academic Positions:
Co-Director, Interdisciplinary Program in Allergy, Immunology and Infectious Disease, 2005 –
present
Associate Dean, USF Medicine International, 2005 – present
Professor, Global Health, College of Public Health, 2005 – present
James Cullison Professor of Medicine, University of South Florida, 2000 – present
Professor, Internal Medicine, University of South Florida, 1994 – present
Director, Division of Infectious Disease and International Medicine, Department of Internal
Medicine, University of South Florida, 1991 – present
Teaching Faculty, University of South Florida Center for HIV Education and Research,
University of South Florida, 1991 – present
Director, Florida Infectious Disease Institute, 2004 – 2006
Associate Professor, Internal Medicine, University of South Florida, 1989 – 1994
Infectious Disease Coordinator, Tampa General Hospital and University of South Florida
College of Medicine, 1985 – 1991
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
2
Assistant and Associate Adjunct Professor, Orthopedics, University of South Florida College of
Medicine, 1984 – 1990
Assistant Professor, Internal Medicine, University of South Florida College of Medicine, 1983 –
1989
Director of Clinical Research, Infectious Diseases and Tropical Medicine, University of South
Florida College of Medicine, 1983 – 1985
Graduate Teaching Assistantship, Department of Biology, University of South Florida, 1971 –
1973
Postgraduate Training:
Fellow, Infectious Diseases and Tropical Medicine, University of South Florida, Tampa, Florida,
1981 – 1983
Resident, Internal Medicine, University of South Florida, Tampa, Florida, 1978 – 1980
Board Certification and Licenses:
Diplomate, American Board of Internal Medicine, Infectious Disease Subspecialty, 1984
Diplomate, American Board of Internal Medicine, 1983
National Board of Medical Examiners, 1978
Private Pilot, Instrument, Federal Aviation Administration (Single and multi-engine, highperformance, complex) (current)
Ships Master (multi-ton vessel), United States Coast Guard, Department of Transportation,
current
Hospital Appointments:
Epidemiologist, Shriner's Children's Hospital, 1987 – present
Director of Epidemiology and Employee Health, Tampa General Hospital, 1985 – present
Chief of Staff, Tampa General Hospital, 1994 – 1996
Vice–Chief of Staff, Tampa General Hospital, 1992 – 1994
Secretary–Treasurer, Medical Staff, Tampa General Hospital, 1990 – 1992
Chief, Department of Internal Medicine, Tampa General Hospital, Tampa, 1988 – 1992
Vice–Chief, Department of Internal Medicine, Tampa General Hospital, 1986 – 1988
Government Appointments:
Senior Advisor to the Secretary of Health, State of Florida, Biodefense, 2001 – 2005
Member, State Formulary Committee, State of Florida, 1999 – 2003
Member, Citizen Healthcare Planning Team, Governor Crist Transition Team, 2006 – 2007
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
3
Laboratory Experience:
Microbiology Quality Advisor, Tampa General Hospital, Tampa, Florida, Sept 1996 – Sept 2004
Director, Microbiology Laboratory, South Florida Regional Bone and Tissue Bank, Lifelink,
Tampa, Florida, Jan 1989 – 2008
Contract Consultant & Quality Director, Clinical Microbiology, Tampa General Hospital,
Tampa, Florida, Aug 1984 – Sept 1996
Editorial Activity:
Editorial Advisory Board, Journal of Health Management, 2009 – present
Editorial Advisory Board, Journal of Health Management, 2006 – present
Medscape Editorial Board, 1999 – 2000
Associate Editor, Infections in Urology, 1991 – 2000
Editor-in-Chief, Infections in Medicine, 1994 – 2009
Medical Editor, Emedicine: Medicine, Obstetrics/Gynecology, Psychiatry, and Surgery, 1999 –
2000
Senior Editor, Antimicrobic and Infectious Diseases Newsletter, 1994 – 2000
Editorial Board, Infections in Medicine, 1992 – 1994
Co-Editor, Contagion, 1992 – 1994
Associate Editor, Infectious Disease Newsletter, 1989 – 1994
North American Editorial Board, Health Information Network. London, England, 1991 – 1992
Board Appointments:
Board Member Ex Officio, Florida Health Science Center Inc. (Tampa General Hospital) Board
of Directors, 2008 – present
Trustee, University of South Florida Foundation, 2006 – present
International Academic Advisory Board, Vivekananda Institute for Leadership Development,
2005 – 2008
Chairman of the Board, Food Tech, VIFL (NASDAQ), 2003 – present
Trustee, Tampa General Hospital Foundation, 1994 – 1996. 2000 – present
Member, Advisory Board, LifeLink of Florida, 1988 – present
Trustee, Hillsborough County Community College Foundation, 2003 – 2006
Board Member, International Biologic Resources, 1995 – 1996
Board Member, Suncoast Aids Network, 1989 – 1993
Member, Board of Directors, Suncoast Florida AIDS Network, 1988 – 1991
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
4
Honors and Awards:
Tampa General Hospital:
Honorary Medical Staff Officer, 2001
Tree of Life Award, 1996
Founding Physician Award, Protective Care Unit, 1989
President's Circle of Excellence, 1987 – 1988
University of South Florida:
Inspire by Example Award, USF Student Affairs, 2011
Dean‟s Academic Performance Award, 2008-2009
Charter Class Mentor, USF Health Leadership Institute, 2006 – present
Faculty, Alpha Omega Alpha, 1989 – present
Silver Performance Award for Outstanding Contributions, College of Medicine, Department of
Internal Medicine, 2006 – 2007
Gold Circle Honoree, 2004
Honors and Awards Council, 1999-2002
Charge to the Graduating Class, College of Medicine, 2001
Charge to the Graduating Class, College of Medicine, 2000
Honorary Alumnus, Alumnae Association, 1998
Provost‟s Award, Faculty-Staff Scholarship Campaign, 1997
Lifetime Appreciation Award, Division of Infectious Diseases, 1996
Outstanding Service Award, Division of Infectious Disease, 1992
Most Outstanding Clinical Professor, 1987, 1988, 1989, 1990, 1991, 1992 (Award Retired and
Renamed "John T. Sinnott Award for Outstanding Clinical Professor," 1992)
Faculty Sponsor, Watson Clinic Award for Outstanding Senior Student Research, 1989, 1991,
1992
Fund-Raising Recognition Award, Faculty Staff Scholarship Campaign, 1990
2nd Place Award, Faculty Sponsor, Student Research Day, 1990
Founding Physician Award, Moffitt Cancer Center Institute, 1986
Outstanding House Officer Award, 1978
Phi Sigma Honor Society, Tampa, Florida, 1973
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
5
Other Awards:
Citation: Leon G. Smith Infectious Disease Institute Hall Of Fame, 2000 – present
Citation: Naifeh S and Smith GW. The Best Doctors in America, 2001 - present
Citation: Who‟s Who in America and Science and Engineering, 1997 – present
Citation: International Who's Who for Professionals, 1996 – present
Finalist, Physician Mentor Recognition Program, American Medical Association – Women
Physicians Congress, 2007
Leadership Florida Distinguished Member Award, Tampa, Florida, 2007
Service Awards, Department of Homeland Security and Immigration Enforcement “In
Recognition of ICE Training.” Presented by Phil Ashton, Immigration Customs Enforcement,
Lantana, Florida, 2007
Lifetime Achievement Award, The AIDS Institute, for “Longtime Dedication to HIV/AIDS
Prevention, Treatment, and Research in the United States and Internationally,” Tampa, 2006
Julia B. Williams Award for Service to Hillsborough County Community College Foundation,
2005
Because We Care Award, Florida Liver Association, Tampa, Florida, 2004
Leadership Florida Class XXI Graduate, 2003
Florida HIV/AIDS Red Ribbon Excellence Award, Bureau of HIV/AIDS, Florida AIDS
Action, 2003
Citation: Best Doctors in Tampa, chosen by Doctors, Tampa Bay Magazine, February 2001,
2003
Finalist, Humanism in Medicine Award, Association of American Medical Colleges, 2001
Citation: Strathmore‟s Who‟s Who, 2001
Citation: Lexington Who‟s Who, 2000
National Beth Israel Humanism Award, NBI Healthcare Foundation, 1998
AIDS Education Award for Dedication and Support of AIDS Education, 1997
AIDS Service Award, FACT (For AIDS Care Today) St. Petersburg, Florida, 1997
Leadership in Medical Education Award, Florida Medical Association, Jacksonville, Florida,
1994
Physician Recognition Award, American College of Pathologists, Chicago, Illinois, 1992
Mayoral Proclamation, "Doctor Marvin R. Dunn and Doctor John T. Sinnott Day," for
Contributions to College of Medicine, City of Tampa, Florida, May 29, 1992
Ciba Geigy Award for Outstanding Teaching, Ciba Geigy Corporation, Woodbridge, New
Jersey, 1992
Honorary Organizing Committee, AIDS Project Quilt, Tampa, FL, 1989, 1992
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
6
Hillsborough County Board Public Institutions Award for Contribution to AIDS Education,
Tampa, Florida, 1991
Philanthropic Award, Shriner's Hospitals for Crippled Children, Tampa Unit, Tampa, Florida,
1991
Clinical Associate Rotation, National Institutes of Health, National Institute of Allergy and
Infectious Disease, Bethesda, Maryland, 1978
Microbiology Award, University of South Alabama College of Medicine, Mobile, Alabama, 1978
American Student Medical Association Prize for Research, 2nd Place, University of South
Alabama College of Medicine, Mobile, Alabama, 1975
Hans Smetana Award, American Hepatic Association, New Orleans, Louisiana, 1974
Committees:
James A. Haley Veterans Administration Hospital:
Member, Acting Chair, Pharmacy and Therapeutics Committee, 1983 – 1988
Shriner’s Children’s Hospital:
Chair, Infection Control Committee, 1987 – present
Member, Institutional Review Board, Shriner's Crippled Children's Hospital, 1990 – 1994
Tampa General Hospital:
Member, TGH Foundation Executive Committee, 2007 – present
Chair, Infection Control Committee, 1985 – 1992, Member, 1992 – present
Member, Cardiac Transplant Committee, 1985 – 2001
Member, Liver Transplant Committee, 1986 – 1999
Member, Clinical Executive Board, 1986 – 2001, Chair, 1994 – 1996
Member, Quality Assurance Committee, 1986 –1990, Chair, 1990 – 1992
Member, Pharmacy and Therapeutics Committee, 1985 – 1992
Member, Pediatric Heart Transplant Committee, 1989 – 1991
Member, Cardiac Transplant Research Committee, 1989 – 1991
Chair, Committee on Clinical Teaching Service, 1989 – 1991
Member, Bio-Ethics Committee, 1987 – 1991
Member, Heart and Lung Transplant Committee, 1986 – 1990
Member, Burn Unit Committee, 1988 – 1990
Member, Ad Hoc Nurse-Physician Liaison Committee, 1988 – 1989
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
7
Member, Ad Hoc Committee on Clinical Pharmacology, 1986
Member, Ad Hoc Committee on Cardiac Transplantation, 1985
University of South Florida College of Medicine:
Mentor, Medical Student Learning Community Mentor Group, 2005 – present
Member, AIMS Committee, University of South Florida, 2005 – present
Member, Voluntary Faculty Promotion Committee, 1996 – present
Chair, Dean's Task Force on AIDS, 1992 – 2002
Member, Departmental Promotion and Tenure Committee, 1990 – present
Team Leader, Faculty/Staff Scholarship Campaign, University of South Florida, 1997, 2004 –
2005
Honors and Awards Council, 2000 – 2003
Committee on Medical Student Affairs, 2000 – 2001
Member, Nominating Committee, Faculty Association, 1991 –1995, 1998
Member, President‟s Council, Faculty/Staff Scholarship Campaign, University of South Florida,
1996 – 1997
Chair, Voluntary Faculty Promotion Committee, 1994 – 1996
Member, Roy H. Behnke Lectureship Honorary Committee, 1995 – 1996
College of Medicine Representative, University of South Florida –Tampa General Hospital
Affiliation Committee, 1993 –1996
Departmental Representative for Medicine, Faculty Association, 1990 – 1996
Member, Dean's Implementation Committee, 1994 – 1995
Chair, Internal Medicine Research Review Committee, 1992 – 1994
Member, Committee on Committees, Faculty Association, 1990 – 1994
Member, Task Force for Continuing Medical Education, 1993
Member, Search Committee, Price Endowed Chair, Department of Pediatrics, 1992 –1993
Chair, Committee on Goals and Objectives, 1990 – 1993
Member, Transplant Oversight Committee, 1986 –1993
Member, College Promotion and Tenure Committee, 1990, Chair, 1991 –1992
Member, Institutional Life and Culture Task Force, University Honors Program, 1990 – 1992
Member, LCME Self-Study Committee on Faculty, 1991
Member, Search Committee, Director of Orthopaedics, 1991
Member, Faculty Senate, 1988 – 1990
Member, Saunders' Scholarship Committee, 1988 – 1989
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
8
Chair, Student Affairs Task Force, 1989
Member, AIDS Committee, 1987 – 1988
Miscellaneous Committees:
Co-Chair, Public Policy Track, United States Conference on AIDS, Houston, Texas, October
2005
Member, Finance Committee, Society for Healthcare Epidemiology, Mt. Royal, New Jersey,
1997 – 2000
Member, Finance Committee, Infectious Disease Society of America, Arlington, VA, 1996 –
1998
Member, Medical Health Advisory Panel, Museum of Science and Industry, 1993
Member, Hillsborough County AIDS Coordinating Council, 1990 – 1992
Teaching Activities:
Director
Leader
Scholarly Concentration in Public Health: Global Approaches to Clinics and
Communities, 2007 – present
Colloquium II: Global Medicine, 2007 – present
PHC 6510
Exotic and Infectious Diseases, College of Public Health,
Lecturer, 2004 – 2008
BMS 6920
Colloquium I/II, College of Medicine, Lecturer, 2004 – present
MEL 8371
Selected Topics in Infectious Disease, 1991 – present
MEL 8357
Infections in Transplant Medicine, Course Director, 1988 – present
BMS 6810
Introduction to Clinical Medicine, Lecturer, 1983 – present
BCC 6110
Internal Medicine Clerkship, Attending, 1983 – present
MEL 9999
Independent Study in Infectious Diseases, Course Director, 1983 – present
MEL 8334
General Internal Medicine Clerkship, Honors Program, 1991 – 1992
MEL 7310
Infectious Disease and Tropical Medicine, Course Director, 1983 – 1991
MEL 7815
Honors Surgery Rotation, Lecturer, Core Curriculum on Surgical Infections,
1991
Volunteer Activities:
Co-Chair, Faculty-Staff Scholarship Campaign, University of South Florida College of Medicine,
Tampa, Florida, 1989, 1995, 2004 – 2010
Founder and Advisor, TGH Foundation Scholars Awards for Medical Students, Tampa, Florida,
1990 – present
Founder and Advisor, Tampa General Hospital Medical Staff Scholarship Awards for Medical
Students, Tampa, Florida, 1989 – present
Numerous Media Interviews and Programs, 1985 – present
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
9
Guest Lecturer, More Health, Tampa, Florida, 1995 – 2000
Co-Founder and Advisor, Students Teaching AIDS to Students (STATS) Program, University of
South Florida, Tampa, Florida, 1987 – 1997
Chairman‟s Award for Outstanding Performance, Faculty-Staff Scholarship Campaign, 1995
Guest Lecturer, Tampa Sertoma Club, Tampa, Florida, 1995
Founder and Co-Director, University of South Florida Health and Rehabilitative Services
Volunteer HIV Clinic, Tampa, Florida, 1992 – 1994
Project Beautiful, Tampa General Healthcare, Tampa, 1994
Founder and Advisor, University of South Florida Housestaff/Tampa General Hospital "Silver
Platter CD" Literature Search Network, Tampa, Florida, 1988 – 1993
Chair, Tampa Bay Medical AIDS Task Force, Tampa, Florida, 1987 – 1990
Volunteer, Judeo-Christian Clinic, Tampa, Florida. 1978 –1989
Consultant, Health Care Task Force: AIDS and the Public Hospital. Florida House of
Representatives, Miami, Florida, 1987
Founder, Protective Care Unit, Tampa General Hospital, Tampa, Florida, 1985
Guest Lecturer, Center for Organizational Development, University of South Florida, Tampa,
Florida, 1985
Founding Board Member, Franklin Memorial Free Clinic, Mobile, Alabama, 1974 – 1977
Guest Lecturer, Medical Explorer Scouts, Mobile, Alabama, 1975 – 1976
Laboratory Volunteer, Clearwater Free Clinic, Clearwater, Florida, 1974
2011 Student Advisees:
2011 Fellow Advisees:
Jane Mai
Jesse Kresak
Leela Mundra
Asa Oxner
Hena Waseem
Michelle Heck
Andrew Myer
Moise Carrington, MD
Elvis Castillo, MD
Ulyee Choe, DO
Rachel Franck, MD
Joseph Katta, DO
Elias Maroun, MD
Tienchai Narach, MD
Georgina Nasr, MD
Luis Rosas, MD
Kevin Smith, MD
International Activities:
Publications:
1. Naik E, Casanas B, Pazare A, Wagale G, Sinnott JT, Salihu H. Cost of treatment: The single
biggest obstacle to HIV/AIDS treatment adherence in lower-middle class patients in Mumbai,
India. Indian J Sex Transm Dis 2009; 30:23-7
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
10
2. *Tucci V, Sinnott JT. A likely case of trichomonal urethritis contracted by oropharyngeal
exposure. Asian Biomed 2008; 2(2):147-149
3. *Houseknecht K, Oliva AM, Sinnott JT. Contact lens-associated Fusarium keratitis: an eye for
trouble. Asian Biomed 2008; 2(1):35-42
4. Pujari SN, Dravid A, Naik E, Bhagat S, Tash K, Nadler JP, Sinnott JT. Lipodystrophy and
dyslipidemia among patients taking first-line, World Health Organization-recommended highly
active antiretroviral therapy regimens in western India. J Acquirimmune Defic Syndr 2005; 39:199202
5. Naik E, Karpur A, Taylor R, Ramaswami B, Ramachandra S, Balasubramaniam B, Galwankar S,
Sinnott JT, Nabukera S, Salihu HM. Rural Indian tribal communities: an emerging high-risk
group for HIV/AIDS. BMC International Health and Human Rights 2005 Feb 21; 5(1):1
6. Sinnott, JT. International Infectious Diseases [Foreword] 2001; 54:157
International Presentations & Abstracts:
1. Sinnott JT, Georgiev H, D‟Souza K, Mundra L, Sistrunk R, Pytlarz J, Wooley J, Lakshmi S. A
University-Corporate Partnership to Enhance Vaccination Rates among the Elderly: An Example of Corporate
Public Health Delivery. Presented to Options for the Control of Influenza VII Conference, Hong
Kong, China, 2010
2. Pujari S, Dravid A, Gupte N, Dhananjay A, Menezes L, Sinnott J. Effectiveness and Safety of Generic
Second-line PI-based ART in Western India. Boston: 15th Annual Conference on Retroviruses and
Opportunistic Infections, 2008
3. Pothiawala S, Menezes L, Deshpande A, Joshi A, Kim H, & Sinnott J. Depressive symptomatology
and suicidal ideation among HIV-infected women in India. Presented at the IV Annual IAS Conference
on HIV Pathogenesis and Treatment, Sydney Australia, 2007
4. Pujari s. Gupte N, Mellinkeri S, Naik E, Menezes L and Sinnott J. Immunologic recovery amongst
virologically suppressed HIV infected individuals in Western India. Los Angeles: 14th Annual Conference
on Retroviruses and Opportunistic Infections, 2007
5. Pujari S, Wills T, Naik E, Menezes L, Nadler J, Norris D, Sinnott JT. Correlates of anemia for HIV
patients in the HAART era: A single-center ambulatory clinical cohort in Pune, India. Presentation at XVI
International AIDS Conference, Toronto, 2006
6. Menezes L, D‟Souza KR, D‟Souza KM, Somboonwit C, Amin S, Sinnott JT. A socio-historical
construction of the AIDS epidemic in India. Abstract: MOPE0724. Presentation at the XVI
International AIDS Conference, Toronto, Canada, 2006
7. Pujari S, Bele V, Joshi K, Sawant S, Joshi S, Nadler J, Sinnott JT, Naik E, Debhade D. Effect of
rifampicin hepatic induction on Nevirapine concentrations in Indian volunteers. Denver: Retroviruses and
Opportunistic Infections, 2006
8. Menezes L, Raja T, Tash K, Naik E, Nadler J, Sinnott JT. Drug use fuels HIV and STDs in a semirural community in India. Rio de Janeiro: IAS Conference on HIV Pathogenesis and Treatment,
2005
9. Naik E, Tash K, D'Souza K, Menezes L, Pazare A, Wable G, Sinnott JT. Cost of treatment: The
single biggest obstacle to treatment adherence in middle class Mumbai, India. Rio de Janeiro: IAS
Conference on HIV Pathogenesis and Treatment, 2005
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
11
10. Oehler RL, Mastorides SM, Toney JT, Gompf SG, Sinnott JT. Comparison of the Treponemal IgG
assay versus conventional RPR analysis in patient screening for the diagnosis of Syphilis. The Challenge,
International Society for Sexually Transmitted Disease Research Congress, Amsterdam, 2005
11. Desai B, Desai M, Naik E, Nadler J, Galwankar S, Tash K, Shah V, Sinnott JT. Can cervical
neoplasia be prevented in HIV patients? Bangkok: International AIDS Conference, 2004
12. Desai B, Desai M, Naik E, Nadler J, Galwankar S, Tash K, Shah K, Sinnott JT. The Effect of
prayer on Depression in HIV patients. Bangkok: International AIDS Conference, 2004
13. Persad A, Galwankar S, Shah V, Sharma A, Naik E, Pathak S, Sinnott JT. Preliminary Results of the
RIHIBlooD Study in Gujarat, India. Barcelona: International AIDS Conference, 2002
14. Singh R, Naik E, Yeolekar M, Taylor R, Galwankar S, Sinnott JT. Profile of Occupational HIV
Exposures in Urban Hospital in Mumbai, India. Barcelona: International AIDS Conference, 2002
15. Karpur A, Naik E, Balasubramaniam R, Seetharam Munnireddy S, Taylor R, Galwankar S,
Sinnott JT. Are Tribals in India at risk of HIV? Barcelona: International AIDS Conference, 2002
16. Sinnott JT, Houston SH, Montero J, Holt D, Slone C, Thadhani S, Reidinger M. Coronary artery
bypass infection. Amsterdam: ICC, 2001
17. Sinnott JT, Houston SH, Larkin JA, Montero JA. Leg closure team and broad spectrum antibiotic
prophylaxis reduces coronary artery bypass infection rate. Hong Kong: First International Congress of the
Asia Pacific Society of Infection Control, 1999
18. Sinnott JT. Infectious diseases following natural disasters. [Speech] Istanbul: ESIDO9, European
Society for Infectious Diseases in ObGyn, 1999
19. Sinnott JT. Infections in OB intensive care. [Speech] Istanbul: ESIDO9, European Society for
Infectious Diseases in ObGyn, 1999
20. Sinnott JT. Nosocomial gynecologic infections. [Speech] Istanbul: ESIDO9, European Society for
Infectious Diseases in ObGyn, 1999
21. Larkin JA, Houston SH, Busciglio L, Sinnott JT. Staphylococcus epidermis endocarditis treated with
RP59500. Barcelona: International Conference on the Macrolides, Azalides, Streptogramins and
Ketolides, 1998
22. Sinnott JT, Holt DA, Houston SH, Bergen G, Sakalosky P, Larkin J, Oehler R. Clarithromycin as
prophylaxis for MAC disease--a follow up. Lisbon: International Conference on the Macrolides
Azalides and Streptogramins, 1996
23. Vincent AL, Ganguly R, Sanders LI, Sinnott JT, Majerus TC, Houston SH, Greene JN. A
BRFSS-based survey of AIDS education and perceptions in Florida [Poster]. Yokohama: International
Conference on AIDS - STDs, 1994
24. Sinnott JT, Houston SH, Majerus TC, Sanders LI, Bergen GA, Ganguly R: Clarithromycin in 500
mg BID as prophylaxis for MAC disease-A retrospective study [Poster]. Yokohama: International
Conference on AIDS, 1994
25. Seeley P, Craig D, Cobian L, Sinnott JT, Greene JN. Health care worker's versus general public's
knowledge of HIV information [Poster]. Yokohama: International Conference on AIDS, 1994
26. Vincent AL, Villanueva LP, Sinnott JT. An immunodiagnostic study of recurrent adeno lymphangitis and
cellulitis ("erisipela") in the Dominican Republic, 1992
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
12
27. Walker JL, Gustke KA, Toney J, Sinnott JT. Centrifugation of antibiotic impregnated bone cement.
Hamilton, Bermuda: Eastern Orthopedic Association, 1987
International Grants and Contracts:
1. Sinnott JT, Menezes L, Naik E, & Wills T. (2005). Training Program on Disaster Management,
Emerging Infections and Trauma Care for Policy Planners and Physicians in Resource Limited
Settings. Government of Maharashtra, India. ($55,200). 05/05-7/05
2. Sinnott JT, Menezes L, Naik E, & Wills T. (2004). HIV Management Training Program for
Physicians in Resource Limited Settings. Government of Maharashtra, India. ($78,200). 09/0411/04
3. Sinnott JT, Menezes L, Naik E, & Wills T. (2004). Training Program for Policy Makers from
Resource Limited Settings. Government of Maharashtra, India. ($15,000). 09/04-11/04
4. Sinnott JT, Naik E, Menezes L & Wills T. (2004). HIV Management Training Program for
Policy Planners and Physicians in Resource Limited Settings. Government of Maharashtra,
India. ($77,400). 6/04-7/04
International Agreements of Collaboration:
University/Organization
Universidad de Panama
Universidad Latina de Panama
Universidad de Carabobo
Gansu Provincial Health Department
Srinakharinwirot University
Yeungnam University
Escuela de Medicina de la Universidad Nacional
Pedro Henriquez Urena (UNPHU)
Policlínico La Vega, SA
Instituto Tecnologico de Santo Domingo
(INTEC)
The Doctor Salvador B. Gautier Hospital
The Directorate of Medical Education and
Research, Government of Maharashtra
Country
Panama
Panama
Venezuela
China
Thailand
South Korea
Dominican
Republic
Dominican
Republic
Dominican
Republic
Dominican
Republic
India
Year
10/09
10/09
10/09
01/09
11/08
05/08
10/07
Role
Initiated & developed
Initiated & developed
Initiated & developed
Initiated & developed
Initiated & developed
Initiated & developed
Initiated & developed
02/07
Initiated & developed
10/06
Initiated & developed
05/06
Initiated & developed
2006
Initiated & developed
International Visiting Professorships
Sinakharinwirot University, Nakorn Nayok, Thailand, December 2002, October 2007
Rungsit University, Thailand, October 2007
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
13
International Memberships:
Editorial Advisory Board, Journal of Health Management, Indian Institute of Health Management
Research, 2005-present
International Academic Advisory Board, Vivekananda Institute for Leadership Development,
2005-present
Other International Activities:
Faculty Advisor, International Health Service Collaborative, USF Health, University of South
Florida, Tampa, 2006 – present
Program Advisor, Stephen Klasko Clinical Observership, Office of International Affairs and the
Division of Infectious Disease, in collaboration with Yeungnam University, South Korea, 2008
Co-Host, Seven National HIV Updates for Indian Physicians, Pune, India, 2000 – 2007
Co-Sponsor, Seven Training Programs (105+ Indian Trainees) Ruby Hall Clinic, Pune, India,
2000 – 2007
Founder, Learning Center with Computer and Broadband Access, Mysore Medical College,
Mysore, India, 2005
Invited Speaker, International Hepatitis B Symposium, Manila, 2005
Co-Sponsor, Training Programs on Disaster Management, Emerging Infections and Trauma
Care for Policy Planners and Physicians (12 Indian Trainees) at University of South Florida,
Tampa, 2005
Co-Sponsor, HIV Management Training Programs (38 Indian Trainees) at University of South
Florida, Tampa, 2004
Founder, CHART-India Training Center, Swami Vivekananda Youth Movement, Mysore, India,
1998
Member, Aid to Russia Committee, Society for Hospital Epidemiology, Washington, DC, 1993 –
1996
Invited Lecturer, Conference on Preventive Medicine in the Caribbean, Pan American Health
Organization, Nassau, Bahamas, 1992
Invited Lecturer, General Hospital and St. George's College of Medicine, St. George, Grenada,
1990
Invited Lecturer, Royal Marsden Cancer Hospital, London, England, 1989
Invited Lecturer, Aberdeen Royal Infirmary, Aberdeen College of Medicine, Aberdeen, Scotland,
1986
Invited Lecturer, As Salam International Hospital, Medical College IV, Cairo, Egypt, 1985
Invited Lecturer, Arab Contractors Medical Center, Medical College IV, Cairo, Egypt, 1985
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
14
International Awards:
MEDSWU Honorable Award presented by the Medical Association of Thailand and the Faculty
of Medicine, Srinakharinwirot University, International Medical Summitt II, Bangkok, Thailand,
2010
Global Leadership Award presented by the HRH Princess Maha Chakri Sirindhorn, Bangkok,
Thailand, 2008
Lifetime Achievement Award, The AIDS Institute, for “Longtime Dedication to HIV/AIDS
Prevention, Treatment, and Research in the United States and Internationally, Tampa 2006
Medical Research Council of Maharashstra, India, HIV Update Award, 2006
Vasai Region AIDS Control Society, Significant Contribution to International Infectious Disease
Issues, India, 2004
The Dr. K. Menda Memorial Oration Award, P.D. Hinduja National Hospital, Mumbai, India,
2003
Contribution Award, Indian Practitioner, Bombay (now Mumbai), India, 2001
Society Membership:
Society of Hospital Epidemiologists of America, 1987 – present
American College of Physicians (Fellow), 1985 – present
Infectious Diseases Society of America (Fellow), 1984 – present
American Society for Microbiology, 1983 – present
American Medical Association, 1978 – present
International Society for Heart Transplantation, 1985 – 2000
American Society for Transplant Physicians, 1989 – 1999
Florida Practitioners of Infection Control, 1986 – 1996
American Society for Tropical Medicine, 1992 – 1994
Physician's Association for AIDS Care, 1988 – 1994
American College of Physician Executives, 1985 –1994
Alabama Academy of Science, 1976 –1978
Publications:
* = Peer-reviewed journal
1.
Shapshak P, Duncan R, Duran EM, Farinetti F, Minagar A, Commins D, Rodriguez H,
Chiappelli F, Pandajarasamme K, Levine AJ, Singer E, Somboonwit C, Sinnott JT. Gene
Expression for HIV-associated Dementia and HIV Encephalitis in Microdissected Neurons I:
Preliminary Analysis. Neurobehavioral HIV Medicine 2011; 3:1-26
2.
Chiappelli F, Somboonwit C, Sinnott JT, Shapshak P. Influenza 2009 Pandemic:
Immunology. Bioinformation, in press, 2011
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
15
3.
Sowmya G, Shamini G, Anita S, Sakharkar M, Mathura V, Rodriguez H, Levine AJ, Singer E,
Commins D, Somboonwit C, Sinnott JT, Siddhu H, et al. HIV-1 Envelope Accessible Surface
and Polarity: Clade, Blood, and Brain. Bioinformation, in press, 2011
4.
Shapshak P, Chiappelli F, Somboonwit C, Sinnott JT. Containing the Influenza Pandemic of
2009: Lessons and Implications. Mol Diagn Ther, in press, 2011
5.
*Mouzakis J, Lakshmi S, Somboonwit C, Rumbak M, Sinnott JT, Cherpelis B. A Case of
Levamisole Induced Purpura and Skin Necrosis in a Cocaine User. J Drugs Dermatol, accepted,
2011
6.
Castillo E, Somboonwit C, Sinnott JT, Shapshak P. West Nile Virus Review, in progress, 2011
7.
Shamini G, Ravishandran M, Sinnott JT, Somboonwit C, Sidhu H, Shapshak P, Kangueane P.
Structural Inferences for Cholera Toxin Mutations in Vibrio cholerae. Bioinformation 2011 Mar;
6(1): 1-9
8.
Sinnott JT, Somboonwit C, Oxner A. Clostridium tetani in a Haitian Refugee. Clin Microbiol
Newsl 2011 Mar; 33(5): 37-39
9.
*Shapshak P, Pandjassarame K, Fujimura RK, Commins D, Chiappelli F, Singer E, Levine A,
Minagar A, Novembre F, Somboonwit C, Nath A, Sinnott JT. NeuroAIDS Review. Editorial.
AIDS 2011; 25:123-141.
10. Shapshak P, Duncan R, Duran EM, Ziegler F, Minagar A, Cummins D, Levine AJ, Singer E,
Somboonwit C, Chiappelli F, Sinnott JT. Gene Chromosomal Organization and Gene
Expression in Neurons Microdissected from Basal Ganglia from Patients with HAD and
HIVE. Bioinformation, in progress, 2010
11. Shapshak P, Somboonwit C, Drumright LN, Frost S DW, Commins D, Tellinghuisen T, Scott
W, Duncan R, McCoy C, Page JB, Giunta B, Fernandez F, Singer E, Levine A, Minagar A,
Oluwadayo O, Kotila T, Chiappelli F, Sinnott JT. Molecular and Contextual Markers of
Hepatitis C Virus and Drug Abuse. Mol Diag Ther 2009; 13(3):153-79
12. Casanas BC, Pothiawala S, Sinnott JT. An Elderly Man with NOMA Orofacial Gangrene. Infect
Dis in Clin Pract 2009; 17(3):208-209
13. *Joseph J, Sinnott JT. [Letter] Web Searches about Physicians. JAMA 2008 Nov 19;
300(19):2249-50
14. *Houseknecht K, Oliva AM, Sinnott JT. Contact lens-associated Fusarium keratitis: an eye for
trouble. Asian Biomed 2008; 2(1):35-42
15. Hussamy D, Sinnott JT. [Book Review] Bone Morphogenetic Protein and Collagen. Cell
Transplant 2006; 15(1):83-84
16. *Billington A, Sinnott JT. [Book Review] The Great Influenza. Infect in Med 2005; 22(8):375
17. Gompf S, Herman B, Tash K, Sinnott JT. Pseudomonas aeruginosa causing a corneal ulcer.
Clin Micro News 2005; 27(8); 15:64-65
18. Vincent AL, Greene JN, Sinnott JT, Rojas CA. Group A Streptococcal Cellulitis with
Lymphedema. Infect in Med 2005 Jul: 317
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
16
19. Pujari S, Sinnott JT, et al. Lipodystrophy and dyslipidemia among patients taking first-line,
WHO-recommended highly active antiretroviral therapy regimes in Western India. J of AIDS
2005 Jun 1; 39(2):199-202
20. Laartz BW, Cooper C, Degryse A, Sinnott JT. A wolf in sheep‟s clothing: Advanced Kaposi‟s
sarcoma mimicking a vulvar abscess. South Med J 2005 Apr; 98(4):475-7
21. Degryse A, Takagishi J, Sinnott JT. A swollen knee and tremor. Clin Pediatr 2004; 43(1):115-7
22. *Wills TS, Lavina J, Sinnott JT. Blastoschizomyces capitatus pneumonia in an immunocompetent
male. South Med J 2004 Jul; 97(7):702-4
23. Elko L, Rosenbach K, Sinnott JT. Cutaneous manifestations of water borne infections. Curr
Infect Dis Rep 2003 Oct; 5(5):398-406
24. *Gill JK, Field T, Vincent AL, Greene JN, Sandin RL, Sinnott JT. Antibiotic susceptibility
among penicillin-resistant pneumococcal isolates in cancer patients. Infect in Med 2003; 20:9
25. *Vincent AL, Sinnott JT. Apparent per capita consumption of cigarettes by Florida counties.
Fl J of Public Health 2003; 13:1
26. Tebes CC, Lynch C, Sinnott J. The Effect of Treating Bacterial Vaginosis on Preterm Labor.
Infect Dis Obstet Gynecol 2003; 11(2):123-129
27. *Sinnott JT, Degryse A. Death and dying [Book Review]. JAMA 2003; 289(2):235-236
28. *Ganguly R, Lenox B, Quiroz E, Sinnott JT. HIV infection, risk factors, and testing in a
veteran population. Amer Clin Lab 2002 Mar; 21(2):32-9
29. *Montero, JA, Zaulyanov, LL, Houston, S. H, Sinnott, JT. Chancroid: an update. Infect in Med
2002; 19:4
30. *Montero JA, Herman B, Bartels LJ, Sinnott JT. Tuberculous otitis. Infect in Med 2002; 19:2
31. *Rosenbach KA, Sinnott JT. Vaccines in the 21st Century. Infect in Med 2001; 18:8
32. *Vincent AL, Vincencio RP, Greene JN, Sandin RL, Sinnott JT. Botfly myiasis in a returning
traveler. Infect in Med 2001; 18:3
33. *Montero JA, Sinnott JT, Holt DA, Lloyd C. Biliary cryptosporidiosis: current concepts. Infect
in Med 2001; 18:312-316
34. Gill JK, Vincent AL, Greene JN, Sandin RL, Sinnott JT. A case-control study of antibiotic
susceptibility among penicillin resistant pneumococcal infections in cancer patients. Infect in Med
2001
35. Bergen GA, Kanowitz SJ, Houston SH, Mbaga II, Sinnott JT. Invasive external otitis with
bilateral renal dissemination caused by Aspergillus fumigatus. Infect in Urol 2000; 13(6):162-164
36. Reidinger M, Sinnott JT. Van Gogh: artist created or artist medicated? Medlennium 2000; 1:32
37. Sinnott JT, Houston SH. A time to die: the place for physician-assistance [Book Review].
JAMA 2000; 283:540
38. Sinnott JT. Survival tip. IFR The Magazine for the Accomplished Pilot 1999; 15:4
39. *Larkin JA, Lit L, Sinnott JT, Wills T. Infection of a knee prosthesis with Tsukamurella
species. A case report. South Med J 1999; 92:831-2
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
17
40. *Vincent AL, Vicencio RP, Greene JN, Sandin RL, Sinnott JT. Botfly myiasis in a returning
traveler. Infect in Med 1999
41. *Larkin JA, Minerva K, Sinnott JT. HIV primer [Book Review]. JAMA 1999; 281:24
42. *Cottam JA, Shenefelt PD, Sinnott JT, Stevens GL, Cancio M, Sakalosky PE. Common skin
infections in the elderly. Infect in Med 1999; 16:4
43. *Mastorides SM, Oehler RL, Greene JN, Sinnott JT, Kranik M, Sandin RL. The detection of
airborne mycobacterium tuberculosis using micropore membrane air sampling and polymerase
chain reaction. Chest 1999 Jan; 115(1):19-25
44. *Sinnott JT, Kneer C, Holt D, Ganguly R. Exposure of medical students to body fluids. J of
Am Coll Health 1999 Mar; 47(5):207-10
45. *Lynch CM, Sinnott JT, Shashy, RG, Murphy SJ. Acute fatty liver of pregnancy: a confusing
clinical entity. Hospital Phys 1999
46. *Sarria JC, Sinnott JT, Martin DH. An AIDS patient with fever and a cough. Infect In Med
1998; 15:1
47. *Larkin JA, Ubillos SS, Sinnott JT, Houston SH. Infection prophylaxis after occupational
exposure to HIV: a simple approach. The AIDS Read 1998; 8:3
48. *Ormerod LD, Sinnott JT, et al. Rapidly progressive herpetic retinal necrosis: a blinding
complication of advanced AIDS. Clin Infect Dis 1998 Jan; 26(1):34-35
49. *Schwandt R, Callahan C, Greene JN, Sinnott JT, D‟Agostino A, Sandin RL. Actinomycosis
mimicking metastatic lung cancer. Infect in Med 1997; (14)10: 791-98
50. *Lynch CM, Pinelli DM, Cruse CW, Spellacy WN, Sinnott, JT, Shashey RG. Maternal death
from postpartum necrotizing fasciitis arising in an episiotomy: a case report. Infect Dis Obstet
Gynecol 1997; 5(5):341-4
51. Vincent AL, Greene JN, Sinnott JT. Cigarette smoking and medical videotapes sold in
pharmacies. J Am Pharma Assoc 1997 Nov-Dec; NS37(6):611-2
52. Glaser V, Hemming VG, Palmer AL, Sinnott JT. Bracing for the cold and flu season. Patient
Care 1997; 9:47
53. *Martinez EJ, Cancio MR, Sinnott JT, Vincent AL. Survival of gastric mucormycosis in a
renal transplant recipient. South Med J 1997 Mar; 90(3):341-4
54. Mastorides SM, Oehler RA, Greene JN, Sinnott JT, Sandin RL. Editorial: detection of
airborne Mycobacterium tuberculosis by air filtration and polymerase chain reaction [Letter]. Clin
Infect Dis 1997 Sep; 25(3):756-7
55. *Houston SH, Sinnott JT. Will microbes inherit the earth? [Editorial] Infect Med 1996; 13:770
56. Sinnott JT, Bergen GA. Update on clarithromycin: highlights and commentary from
presentations at an international meeting. [Editorial]. Infect in Med 1996; 13:9
57. Sinnott JT, Larkin JA, Shashy RG. Death [Book Review]. JAMA 1996; 23:1921
58. *Bergen GA, Sakalosky PE, Sinnott JT. Transient aplastic anemia caused by parvovirus B19
infection in a heart transplant recipient. J of Heart Lung Transplant 1996 Aug; 15(8):843-5
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
18
59. Sinnott JT, Quinlan LA. Private office laboratories: coping with new federal guidelines
[Editorial]. Infect in Urology 1996; 9:181
60. Bergen GA, Nadler JP, Houston SH, Gompf S, Sinnott JT. Nocardia Bacteremia: Case
Reports and Review of the Literature. Infect Dis in Clin Prac 1996; 5:3
61. Yag-Howard C, Fitsmorris K, Pullara T, Sinnott J. Seabather‟s Eruption Developing in An
Individual Not Directly Exposed to Sea Water. South Med J 1996; 89(10):S28
62. Nadler JP, Larkin JA, Saba S, Sinnott JT. Sepsis and meningitis caused by Capnocytophaga
canimorsus in an immunocompetent host: case report and review of microbiology. Antimicrobics
and Infect Dis News 1996; 15:25-26
63. Bergen GA, Gompf SG, Sakalosky PA, Sinnott JT. Influenza: more than Mom and chicken
soup. J Fla Med Assoc 1996 Jan; 83(1):19-22
64. *Brown MA, Greene JN, Sandin RL, Hiemenz JT, Sinnott JT. Methlobacterium sp. bacteremia
after infusion of contaminated autologous bone marrow. Clin Infect Dis 1996 Nov; 23(5):1191-2
65. *Foster J, Greene JN, Sandin RL, Sinnott JT, Spoto VM, Hitchcock CL, Karl R, Vincent AL.
Small-bowel perforation in patients with AIDS: two case reports and a review of the literature.
Infect Med 1996; 4:294
66. *Houston SH, Sinnott JT. Management of the transplant recipient with pulmonary infection.
Infect Dis Clin North Am 1995 Dec; 9(4):965-85
67. *Cobian L, Houston SH, Greene JN, Sinnott JT. Moraxella nonliquefaciens septic arthritis in a
patient undergoing hemodialysis. Clin Infect Dis 1995; 21:1039-1040
68. *Conrad MK, Sinnott JT, Albrink M, Sakalosky P. Gastric cancer: an infectious disease?
Cancer Control 1995 Nov; 2(6):541-547
69. Sinnott JT, Thompson P. The expanding horizons of infection control [Letter]. Infect Cont
Hosp Epidemiol 1995 Nov; 16(11):620
70. Karl FB, Mandelblatt D, Sinnott JT. One hundred years of medicine. Hillsborough County Med
Assoc Bulletin 1995; l41: 3
71. Martinez EJ, Sinnott JT, McKeown PP, Nord HJ, Weinstein SS, Holt DA, Saba HI, Canedo
M. Hemolytic anemia: a new herald for Kaposi's sarcoma in cardiac transplantation. South Med
J 1995
72. *Riker AI, Cancio MR, Houston SH, Sinnott JT. Clostridium difficile osteomyelitis following
traumatic leg injury. Infect Med 1995; 8:378
73. *Greene JN, Sinnott JT, Wyckoff, JA, Carter L, Sandin RL. Bacterial infection following
blood product transfusion: some bad blood bugging you? Infect Med 1995; 4:165
74. Houston SH, Greene JN, Provencher DE, Ison MG, Sinnott JT. Mycobacterium leprae -an
ancient scourge today. J Fla Med Assoc 1995
75. *Cobian L, Houston SH, Greene JN, Sinnott JT. Parainfluenza virus respiratory infection
after heart transplantation successfully treated with ribavirin. Clin Infect Dis 1995 Oct;
21(4):1040-1
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
19
76. *Houston SH, Lipp K, Cobian L, Sinnott JT. Skin rash in a renal transplant recipient. Hospital
Pract 1995 May 15; 30(5):89-90
77. Sinnott JT. We're working to reveal the best-kept secret [Editorial]. MedNotes 1995; 4:1
78. *Ubillos SS, Vuong D, Sinnott JT, Sakalowsky PE. Seabather's eruption. South Med J 1995
Nov; 88(11):1163-5
79. Sinnott JT. Sally's tips for sensitive doctoring [Letter]. J Fla Med Assoc 1994; 12:804
80. *Houston SH, Vincent AL, Cobian L, Sinnott JT. Strongyloides related sepsis in AIDS
patients. Antimicrobics Infect Dis News 1994; 13:41
81. *McCloskey RV, Straube RC, Sanders C, Smith SM, Smith CR, Chess trial study group (Sinnott
JT). Treatment of septic shock with human monoclonal antibody HA-1A. Ann Intern Med
1994; 121:1
82. *Sinnott JT, Mayer CA, Cancio MR, Powell C. Prions: a unique cause of transmissible
dementias. Infect Med 1994; 11: 381
83. *Rushton TC, Ganguly R, Sinnott JT, Banerji M. Barriers to immunization-an examination of
factors that influence the application of pneumococcal vaccine by house staff. Vaccine 1994
Oct; 12(13):1173-9
84. Sinnott JT, Ragsdale R, Bergen G, Padios MM. Probing for answers: DNA probes in
infectious disease. J Fla Med Assoc 1994 Aug; 81(8):543-5
85. Sinnott JT, Rushton T, Holt DA, Freeman TB, Olanow CW, Sarzier JS. Infectious disease
issues in fetal tissue transplantation for Parkinson‟s disease. Infect Dis News 1994; 12:65
86. *Houston SH, Greene JN, Padios MM, Cobian L, Sinnott JT. Suppurative thyroiditis. Infect
Med 1994; 12:774
87. *Houston SH, Sinnott JT, Murphy SJ, Larkin JA, Greene JN. Chickenpox in pregnancy. Infect
Med 1994; 8:564
88. *Sinnott JT, Greene JN, Kim E, Gompf SG. Hantavirus: an old bug learns new tricks. Infect
Cont Hosp Epidemiol 1993 Nov; 14(11):661-4
89. Sinnott JT, Cancio MR, Lynch CM, Murphy SJ. Acute fatty liver of pregnancy presenting as
hepatitis. West Med J 1993
90. Markowsky SJ, Sinnott JT, Houston SH. Selective decontamination of the digestive tract in
intensive care patients. Infect Dis News 1993; 12:7
91. Sinnott JT. AIDS: palpating the pachyderm [Editorial]. Oracle 1993
75. Vincent AL, Holt DA, Houston SH, Sinnott JT. Fever and arthralgia in a medical student.
Infect Dis News 1993; 12:6
76. Albrink MH, Sinnott JT. Laparoscopic cholecystectomy: infectious disease implications. Infect
Dis News 1993; 12:6
77. Houston SH, Glossa JS, Fisher A, Montero J, Rushton TR, Sinnott JT. Immunization of the
organ transplant recipient. Infect Dis News 1993; 12:86-87
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
20
78. Vincent AL, Cancio MR, Sinnott JT. Filariae and streptococci in "tropical lymphangitis" with
lymphedema. Infect Dis News 1993; 12:7
79. Bowers VA, Sinnott JT, Flores R. Antibiotic interactions with FK506: a novel
immunosuppressant. Infect Dis News 1993; 12:6
80. *Holt DA, JT, Baran DA, Oehler RL, Sinnott JT. Delta hepatitis: diagnostic algorithms. Infect
Med 1993; 10:23
81. *Sinnott JT, Roskein D, Stern R, Bradley E. Intraamniotic infections: a major factor in
preterm delivery. Infect Dis News 1993; 12:73
82. *Greene JN, Sandin RL, Villanueva L, Sinnott JT. Haemophilus parainfluenzae endocarditis in a
patient with mitral valve prolapse. Ann Clin Lab Sci 1993 May-Jun; 23(3):203-6
83. *Oehler RL, Sinnott JT, Arepally G, Dunn YP. An unusual case of Kaposi's sarcoma
mimicking cellulitis. Postgrad Med 1993 Dec; 94(8):139-44, 149
84. Holt DA, Sinnott JT, Van Sant S, Behnke RH, Lipp K. A medical history timeline. Florida
medical society. J Fla Med Assoc 1993 Feb; 80(2):121-3
85. *Martinez EJ, Sinnott JT, Rodriguez-Paz, Oehler R. Lithium induced nephrogenic diabetes
insipidus treated with indomethacin. South Med J 1993 Aug; 86(8):971-3
86. Sinnott JT, Gompf TC, Gonzalez-Gompf S. Congenital tuberculosis. Infect Dis News 1992; 2:5
87. *Hill DA, Sinnott JT, Holt DA, Cancio MR. A patient who got darker on zidovudine therapy.
Hosp Pract 1992 Feb 28; 27(2A):29-30
88. *Sinnott JT, Cacciatore ML. Measles in pregnancy: physician on the spot. Infect Med 1992; 9:45
89. Sinnott JT, Barry KC. Dangerous marine life: how to deal with these injuries. Ocean Voyager
1992; 1:23
90. *Holt DA, Sinnott JT, Bradley EA. Nosocomial prostatitis. Infect Med 1992; 5:139
91. *Holt DA, Sinnott JT, Oehler RL, Bradley EA. BK virus. Infect Cont Hosp Epidemiol 1992 Dec;
13(12):738-41
92. *Sinnott JT, Oehler RL, Baran DA, Holt DA. Relapsing fever: ticked off by a lousy illness.
Infect Med 1992; 9:18
93. *Chan G, Sinnott JT, Emmanuel PJ, Yandle S. Drug interactions with cyclosporine: focus on
anti-microbial agents. Clin Transplant 1992; 6:141
94. *Esperanza L, Holt DA, Sinnott JT, Cancio MR, Bradley EA, Deutsch M. Murine typhus:
forgotten but not gone. South Med J 1992 Jul; 85(7):754-5
95. *Taylor E, Sinnott JT. Ehrlichiosis. Infect Cont Hosp Epidemiol 1992 Feb; 13(2):104-6
96. *Holt DA, Sinnott JT, Toney JF, Greene JN. Chlamydia one dose treatment with
azithromycin. Clin Research 1992; 40:2
97. *Finan M, Smith S, Sinnott JT, O'Brien W, et al. An interesting case presentation: peripartum
meningococcal meningitis. J of Perinatology 1992 Mar; 12(1):78-80
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
21
98. *Chan GL, Kahana L, Weinstein SS, Sinnott JT. The effect of prophylactic aminoglycoside on
early function in cadaveric renal transplant patients receiving cyclosporine. Pharmacotherapy
1992; 12:6
99. Sinnott JT. How does HCV antibody titer correlate with infectivity? [Letter].Cortland Forum
1991; 1:81
100. Russell DW, Cameron DJ, Lockey RF, Behnke RH, Sinnott JT, Ganguly R. Vaccine 1991 Sep;
9(9);691-2
101. Sinnott JT, Esperanza L, Holt DA, Thompson F. Hantavirus. Infect Dis News 1991; 10:51
102. Sinnott JT, Garland LL. Leuconostoc. Infect Dis News 1991; 10:33
103. *Lynch CM, Sinnott JT, Holt DA, Herold AH. Use of antibiotics during pregnancy. Am Fam
Physician 1991 Apr; 43(4):1365-8
104. Lynch CM, Holt DA, Sinnott JT. Human parvovirus B19 and pregnancy. Infect Dis News 1991;
10:87
105. *Holt DA, Pattani NJ, Sinnott JT, Bradley EA. Lyme borreliosis. Infect Cont Hosp Epidemiol
1991 Aug; 12(8):493-6
106. *Sinnott JT, Albers SE, Holt DA. Postanginal sepsis with dysphagia. South Med J 1991 Mar;
84(3):385-6
107. *Ganguly R, Russell DW, Yangco BV, Chmel H, Cameron DJ, Sinnott JT. Influenza
vaccination status among health care professionals for prevention of nosocomial infection in
hospitalized elderly patients. Serodiagnosis and Immunotherapy in Infect Dis 1990; 4:309
108. *Larkin J, Sinnott JT, Weiss J, Holt DA. Human T-cell lymphotropic virus type-1. Infect
Control Hosp Epidemiol 1990 Jun; 11(6):314-8
109. *Holt DA, Prieto J, Sinnott JT. Human herpes virus-6. Infect Dis News 1990; 9:17
110. *Sinnott JT, Emmanuel PJ. Mycobacterial infections in the transplant patient. Semin Respir
Infect 1990 Mar; 5(1):65-73
111. *Sinnott JT, Alverez C, Greene J, Sweeney MJ, Holt DA. Nocardia brasiliensis cellulitis in a
heart transplant patient. Texas Heart Inst J 1990; 17(2):133-5
112. *Sinnott JT, Cancio MR, Frankle MA. Tuberculous osteomyelitis masked by concomitant
staphylococcal infection. Arch Intern Med 1990 Sep; 150(9):1865-7
113. *Sinnott JT, Rodnite J, Emmanuel PJ. Cryptococcus laurentii infection complicating peritoneal
dialysis. Ped Infect Dis J 1989 Nov; 8(11):803-5
114. *Rogers KR, Sinnott JT, Ferguson JE. Using OKT3 to reverse cardiac allograft rejection.
Heart Lung 1989 Sep; 18(5):490-6
115. Sinnott JT, Blazejowski C, Bazzini MD. Bordetella bronchiseptica endocarditis: a tale of a boy
and his dog. Clin Microbiol News 1989; 11:14
116. *Sinnott JT, Rodnite J, Ruland R. What is it? Orbital or periorbital cellulitis? Postgrad Med 1989
May; 85(6):267-9
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
22
117. Toney JF, Sinnott JT, Ivey P. Infections in bone marrow transplantation. Infect Dis News 1989;
8:8
118. *Sinnott JT, Gasser S, Kilgore J: Tuberculosis Masquerading as Neoplasia: A Sheep in Wolf's
Clothing. Hosp Pract 1989 Sept 15; 24(9):153-6
119. Sinnott JT, DiCarlo RL, Villanueva LP, Himelright IM. Infections in liver transplantation.
Infect Dis News 1989; 8:57
120. *Sinnott JT, Wheedon C, Schwartz M. Post anginal sepsis: a pain in the neck. Postgrad Med
1989 Aug; 86(2):77-8, 81-2
121. Sinnott JT, Rushton T, Kilgore J. Infections in heart transplantation. III. Infect Dis News 1989;
8:57
122. *Sinnott JT, Himelright IM. Chlamydia species strain - TWAR. Infect Cont Hosp Epidemiol 1989
Apr; 10(4):175-7
123. *Sinnott JT, Coleman D, Cheek J, Rubin RW. Infections in renal transplantation. Infect Dis
News 1989; 8:41
124. *Sinnott JT, Multhopp H, Leo J, Rechtine G. Yersinia enterocolitica causing spinal Osteomyelitis
in a in a nonimmunocompromised host. South Med J 1989 Mar; 82(3):399-400
125. Sinnott JT, Carballo FE, Holt DA, Rubin RW. An introduction to organ transplantation. Infect
Dis News 1989; 8:34
126. *Sinnott JT. Infections in the Rheumatic Diseases [Book Review]. J of Ortho Trauma 1989;
3:185
127. Sinnott JT, Turnquest DG, Milam MW. Plesiomonas shigelloides gastroenteritis. Clin Microbiology
News 1989; 11:13
128. *Sinnott JT, Holt DA. Cryptococcal pyarthrosis complicating gouty arthritis. South Med J 1989
Dec; 82(12):1555-6
129. Sinnott JT, Blanco P, Cullison JP. Capnocytophagia: a case report. Infect Dis News 1988; 7:53
130. *Sweeney MS, Macris MP, Frazier OH, Peric M, Sinnott JT, McAllister HA. The treatment of
advanced cardiac allograft rejection. Ann Thorac Surg 1988 Oct; 46(4):378-81
131. *Sinnott JT, Gilchrist L, Ellis L. Respiratory syncytial virus. Infect Control Hosp Epidemiol 1988
Oct; 9(10):465-8
132. *Sinnott JT, Cullison JP, Sweeney MS, Weinstein SS. Infections in patients receiving OKT3
monoclonal antibody for cardiac rejection. Texas Heart Inst J 1988; 15(2):102-6
133. *Walker JL, Gustke KA, Toney JF, Sinnott JT. Centrifugation of antibiotic impregnated bone
cement. Orthopedics 1988; 6:891
134. *Sinnott JT, Cullison JP, Blanco P. Capnocytophagia. Infect Cont Hosp Epidemiol 1988 April;
9(4):170-3
135. *Sinnott JT, Cullison JP, Sweeney MS, et al. Respiratory syncytial virus pneumonia in a
cardiac transplant patient. J Infect Dis 1988 Sep; 158(3):650-1
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
23
136. *Sinnott JT, Trout T, Berger L. The „swimming-pool granuloma‟ that wouldn't heal. Hosp
Pract 1988 Feb 15; 23(2):82-4
137. *Sinnott JT, Milam M. Cholangitis 1987. Abdom Surg 1988; 30:16
138. *Sinnott JT, Cancio M. Rotavirus. Infect Control 1987 Dec; 8(12):519-21
139. *Sweeney MS, Sinnott JT, Cullison JP, Weinstein SS. The use of OKT3 for stubborn allograft
rejection: an advance in clinical immunotherapy. J Heart Transplant 1987 Nov-Dec; 6(6):324-8
140. *Sinnott JT, Cullison JP, Sweeney MS. Candida (Torulopsis) glabrata. Infect Control 1987 Aug;
8(8):334-6
141. *Sinnott JT, Cullison JP, Rogers K. The treatment of cytomegalovirus gastrointestinal
ulceration in a cardiac transplant patient. J Heart Transplant 1987 May-Jun; 6(3):186-8
142. Sinnott JT, Cancio MR. Cytomegalovirus. Infect Control 1987 Feb; 8(2):79-82
143. Sinnott JT, Feldman D. Chromo bacteriosis - Florida. MMWR, Centers for Disease Control
1981; 29:51
144. Sinnott JT, Craig CP. Endotoxin clearance by Kupffer cells in Venezuelan equine encephalitis
infected mice. Alabama J of Med Sciences 1974; 80:1
Textbooks Chapters & Misc.:
1.
Shapshak P, Singer E, Commins D, Chiappelli F, Levine A, Minagar A, Somboonwit C,
Sinnott JT. Inflammation in NeuroAIDS. In progress, 2010
2.
Wills T, Sinnott JT, Alrabaa S. Viral Hemorrhagic Fevers. APIC Text of Infection Control
and Epidemiology, 3rd ed. Association for Professionals in Infection Control and Applied Epidemiology
Principles and Practice (APIC). Washington, 2009
3.
Asthana D, Fischl M, Sachdeva N, Teppler H, Sinnott J, Saag M. Host Response. In: Mildvan
D ed. International Atlas of AIDS, 4th ed. Philadelphia: Current Medicine Group, 2008
4.
Sinnott JT, Casanas B, Cooks A, Cooper C, et al. Abdominal Infections. In: MacCue J, Kahan
S eds. In A Page Infectious Disease. Baltimore: Lippincott Williams & Wilkins, 2006
5.
Sinnott JT. Vancomycin-Resistant Enterococcus. In: MacCue J, Kahan S eds. In A Page
Infectious Disease. Pittsburgh: Lippincott, Williams & Wilkins, 2006
6.
Somboonwit C, Poklepovic A, Irvine L, Sinnott JT. Infectious disease aspects of viral
hemorrhagic fever. In: Soule BM ed. The American Practitioner in Infection Control. St. Louis:
Mosby-Year Book, Inc., 2004
7.
Houston SH, Sinnott JT. Hantavirus pulmonary syndrome. APIC Infection Control and Applied
Epidemiology Principles and Practice. St. Louis: Mosby-Year Book, Inc., 2004
8.
Degryse A, Houston SH, Sinnott JT. Dengue virus. In: Kean L, ed. Association for Professionals
in Infection Control and Applied Epidemiology Principles and Practice. St. Louis: Mosby-Year Book,
Inc., 2004
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
9.
24
Rosenbach KA, Houston SH, Sinnott JT, Shea JP. Infectious disease aspects of employee
(occupational) health. In Betts RF, Chapman SW, Penn RL, eds. Reese and Betts’: A Practical
Approach to Infectious Disease, 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2003:957
10. Houston SH, Rubin RH, Sinnott JT. Infections in transplantation. In: Betts RF, Chapman
SW, Penn RL, eds. Reese and Betts’: A Practical Approach to Infectious Disease, 5th ed. Philadelphia:
Lippincott Williams & Wilkins, 2003; 20:782
11. Rosenbach KA, Houston SH, Sinnott JT, Shea JP. Infectious disease aspects of employee
(occupational) health: A brief overview. In: Reese RE, and Betts RF, eds. A Practical Approach
to Infectious Diseases. Toronto: Little Brown, 2002
12. Houston SH, Sinnott JT. Infections in transplantation. In: Reese RE, and Betts RF, eds. A
Practical Approach to Infectious Diseases, Toronto: Little Brown, 2002
13. Huguet K, Houston SH, Casatelli J, Sinnott JT. Dengue virus. APIC Infection Control and
Applied Epidemiology Principles and Practice. St. Louis: Mosby-Year Book, Inc. 2000;118:6-11
14. Sinnott JT, Rosser WW, Williams ML, et al, eds. Clinical Internal Medicine. Peking, China:
Chinese University Press, 1999
15. Larkin JA, Houston SH, Sinnott JT. Infections in transplant patients. In: Sharpe MD, and
Gelb AW, ed. Anesthesia and Transplantation. Boston: Butterworth-Heinemann, 1999
16. Kim E, Sinnott JT. Hantavirus. In: Soule BM, ed. The American Practitioners in Infection Control
Curriculum for Infection Control Practice. St. Louis: Mosby, 1996
17. Casetelli J, Ison M, Houston SH, Sinnott JT. Dengue virus. In: Soule BM, ed. The American
Practitioners in Infection Control Curriculum for Infection Control Practice. St. Louis: Mosby, 1996; 81:7
18. Larkin JA, Houston SH, Sinnott JT, LeFor WM. Serologic screening of potential organ
donors. UNOS Organ Procurement, Preservation and Distribution in Transplantation, 2nd Ed.,
Richmond: UNOS, 1996
19. Sinnott JT, Houston SH, Shea JP. Infectious disease aspects of employee health. In:
Reese RE, and Betts RF, eds. A Practical Approach to Infectious Disease 4th ed. Boston,
Toronto: Little Brown, 1996: [Appendix B] 1406-1416
20. Houston SH, Rubin RH, Sinnott JT: Infections in transplantation. In: Reese RE and Betts
RF, eds. A Practical Approach to Infectious Disease 4th ed. Boston, Toronto: Little Brown, 1996;
20:785-811
21. Larkin JA, Houston SH, Sinnott JT. Skin infections in the elderly. In: Cooper JW, ed. Antiinfectives in the Elderly. Binghamton: The Haworth Press, Inc. 1995:51-67
22. Ison MG, Larkin JA, Houston SH, Sinnott JT. Fungal infections: Cryptococcus neoformans,
Fungal infections: Histoplasma capsulatum, Fungal infections: Coccidioides immitis, Fungal
infections: Aspergillus, Fungal infections: treatment of AIDS-related mycoses: a review of side
effects and drugs. Jacksonville Florida Medical Association Clinical Manual on HIV and AIDS, 2nd
ed. 1995
23. Larkin JA, Houston SH, Sinnott JT. Infections in the transplant patient. In: Sharpe M, ed.
Anesthesia and Transplantation. Newton: Butterworth/Heinemann, 1995
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
25
24. Houston SH, Sinnott JT. Management of pulmonary infiltrates in the transplant recipient. In:
Rubin RH, ed. Infectious Disease Clinics of North America. Philadelphia: WB Saunder, 1995
25. Holt DA, Sinnott JT, Kim E. Fever of unknown origin. In: Neu H, ed. Current Practice of
Medicine. Philadelphia: Current Medicine Press, 1994
26. Sinnott JT, Rubin RH. Infections in transplantation. In: Reese RE, and Betts RF, eds. A
Practical Approach to Infectious Disease, 3rd ed. Boston, Toronto: Little/Brown, 1991
27. Sweeney MS, Frazier OH, Sinnott JT, O'Connell JB. The use of monoclonal antibodies in
treating cardiac allograft rejection: Our experience with OKT3. In: Reichart B, Fasol R, et al.,
eds. Recent Advances in Cardiovascular Surgery. Munich, Germany: R.S. Schulz, 1989
28. Sinnott JT, Cullison JP. Epstein-Barr virus (Revision). In: Soule BM, ed. The American
Practitioners in Infection Control Curriculum for Infection Control Practice. Dubuque: Kendall/Hunt,
1988
29. Sinnott JT, Cullison JP. Varicella-zoster virus (Revision). In: Soule BM, ed. The American
Practitioners in Infection Control Curriculum for Infection Control Practice. Dubuque: Kendall/Hunt,
1988
30. Sinnott JT, Cancio M. Cat scratch disease. In: Soule BM, ed. The American Practitioners in
Infection Control Curriculum for Infection Control Practice. Dubuque: Kendall/Hunt, 1988
31. Sinnott JT, Cancio M. Respiratory Syncytial Virus (Revision). In: Soule BM, ed. The American
Practitioners in Infection Control Curriculum for Infection Control Practice. Dubuque: Kendall/Hunt,
1988
32. Sinnott JT, Cancio M. Cytomegalovirus (Revision). In: Soule BM, ed. The American Practitioners
in Infection Control Curriculum for Infection Control Practice. Dubuque: Kendall/Hunt, 1988
33. Sinnott JT, Cancio M. Herpes simplex virus. (Revision) In: Soule BM, ed. The American
Practitioners in Infection Control Curriculum for Infection Control Practice. Dubuque: Kendall/Hunt,
1988
Abstracts and Presentations:
1.
Sinnott, JT. Policy Implications for HIV/AIDS of the Ryan White CARE Act Reauthorization 2005.
St. Louis: North American AIDS Treatment Access Forum (NATAF) Conference, 2006
2.
Grafals M, Gompf S, Herman B, Tash K, Sinnott JT. Pseudomonas corneal ulcer: An ocular
emergency. Jacksonville: American College of Physicians, Florida Chapter, 2004
3.
Ganguly R, Toney JF, Quiroz E, Jacob S, Poblete SJ, Montero JA, Sinnott JT: HIV infection.
Behavioral practices in a veteran population. Infectious Diseases Society of America, 1999
4.
Ganguly R, Banerji M, Sinnott JT, Holt DA, Larkin JA, Houston SH, Quiroz E, Poblete S,
Thomas G, Busciglio L. Influenza vaccine application in internal medicine clinics. Atlanta: American
Society of Microbiology, 1998
5.
Mastorides SM, Oehler RL, Greene JN, Sinnott JT, Sandin RL. Detection of mycobacterium
tuberculosis by using air filtration and polymerase chain reaction. ACJP, 1998:470
6.
Sinnott JT. Tuberculosis (TB) prevention strategy of physicians in residency training. San Francisco:
Infectious Disease Society of America, 1998
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
26
7.
Kneer C, Bradley EA, Poblete SA, Sinnott JT, Holt D, Ganguly. Practice of universal precautions
guidelines (UVPG) in occupational settings. San Francisco: Infectious Diseases Society of America,
1998
8.
Montero J, Mbaga I, Larkin JA, Sinnott JT, Shashy R, Ballow C: Enterococcal bacteremia:
vancomycin resistant (VRE) compared to sensitive (VSE) strains. New Orleans: American Federation
for Medical Research, 1998
9.
Ganguly R, Sinnott JT, Houston SH, Toney JT, Holt DA, Cobian L. Hepatitis B virus vaccine: a
measure against occupationally acquired infection. San Francisco: Infectious Disease Society of
America, 1997
10. Vincent AL, Ayoub EM, Ottesen EA, Sinnott JT. Streptococci and Filariae as causes of lymphedema
in Santo Domingo. San Francisco: Infectious Disease Society of America, 1997
11. Ganguly R, Toney JT, Holt DA, Sinnott JT, Carney M, Cobian L, Desai V: Occupational risks of
hepatitis B virus infection among older health care providers (HCP). Tampa: 1997 Research Day,
University of South Florida, 1997
12. Ganguly R, Sinnott JT, Carney M, Cobian L, Desai V, Toney J, Holt DA, Busciglio L,
Callahan C, Mbaga I, Montero J. Occupational risks of hepatitis B virus infection. Miami: American
Society for Microbiology, 1997
13. Ganguly R, Marty P, Herold A, Desai V, Anderson M, Sinnott JT, Holt DA, Larkin JA,
Quiroz E, Callahan C, Mbaga I. Hepatitis B virus vaccine cost: a barrier to immunization. Miami:
American Society for Microbiology, 1997
14. Larkin JA, Houston SH, Holt DA, Sinnott JT, Oehler R, Alexander LA. Reduction in
contaminated allograft bone cultures by a tissue handling protocol. New Orleans: American Federation for
Medical Research, 1997
15. Bergen G, Toney J, Oehler R, Houston SH, Ketch R, Vincent AL, Sinnott JT. The use of
Thallium-201 scanning in the diagnosis of central nervous system lesions in HIV-infected persons. New
Orleans: Infectious Diseases Society of America, 135, 1996
16. Yag-Howard C, Fitzmorris K, Pullara-Brandt T, Sinnott JT. Seabather's eruption in an individual
not directly exposed to seawater. Baltimore: Southern Medical Association, 1996
17. Toney JF, Bergen GA, Sinnott JT, Vincent AL, Ganguly RA, Schmitt K, Wroten JE. Sexually
transmitted diseases attitudes and knowledge in county public health care units. Tampa: National STD
Prevention Conference, 1996
18. Toney JF, Bergen GA, Sinnott JT, Vincent AL, Ganguly RA. Sexually transmitted diseases
attitudes and knowledge in county public health care units. New Orleans: The Infectious Disease Society
of America, 1996
19. Ganguly RA, Marty P, Herold A, Carney M, Sinnott JT. Prevention of hepatitis B virus among
university students. New Orleans: Infectious Disease Society of America, 1996
20. Vincent AL, Ganguly RA, Sinnott JT, Carney M, Hoechrel S. Knowledge and perception of AIDS
transmission among Floridians. New Orleans: Infectious Disease Society of America, 1996
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
27
21. Larkin JA, Ison M, Houston SH, Clarkson E, Sakalosky P, Sinnott JT. Infection control plan
reduces cardio-thoracic (CT) surgical site infections. New Orleans: Infectious Disease Society of
America, 1996
22. Houston SH, Holt DA, Sinnott JT, Oehler R, Larkin JA, Alexander LA. Reduction in
contaminated allograft bone cultures by a tissue handling protocol. New Orleans: Interscience Conference
on Antimicrobial Agents and Chemotherapy, 1996
23. Houston SH, Oehler R, Holt DA, Sinnott JT, Bergen G, Ison MG. Education reduces
contaminated blood cultures rates in a pediatric emergency department. New Orleans: Interscience
Conference on Antimicrobial Agents and Chemotherapy, 1996
24. Houston SH, Ison MG, Willis D, Sinnott JT, Jani A. Cat-scratch disease – a case report and clinical
update. Southern Medical Journal, 1995
25. Ganguly R, Herold A, Anderson M, Jani A, Sinnott JT. Hepatitis B infection among university
students. Washington, DC: American Society for Microbiology, 1995
26. Vincent AL, Ganguly R, Sinnott JT, Hoecherl S. AIDS knowledge and acceptance by Floridians. San
Francisco: Infectious Disease Society of America, 1995
27. Ison MG, Houston SH, Pattani S, Cobian L, Sinnott JT. Parvovirus B19 infection in cardiac
transplant patients. San Francisco: Infectious Disease Society of America, 1995
28. Ganguly R, Vincent A, Sinnott JT, Hoecherl S. Influenza vaccination behavior among Floridians. San
Francisco: Infectious Disease Society of America, 1995
29. Ganguly R, Vincent AL, Sinnott JT, Hoecherl S. Psychological perceptions about AIDS risks among
Floridians. Las Vegas: American Society of Microbiologists, 1994
30. Rushton TC, Ganguly R, Sinnott JT, Banerji M. Pneumococcal vaccine acceptance in university-related
clinics. Orlando: Infectious Disease Society of America, 1994
31. Kneer C, Sinnott JT, Bradley E, Ganguly R: Medical student exposure to body fluids. Orlando:
Infectious Disease Society of America, 1994
32. Rushton TC, Ganguly R, Sinnott JT. Pneumococcal vaccine usage by internal medicine residents
[Poster]. Orlando: Florida Chapter, American College of Physicians, 1993
33. Rushton TC, Ganguly R, Sinnott JT. Pneumococcal vaccine knowledge and attitude among internal
medicine. New Orleans: American Society for Microbiology, 1993
34. Mayer CA, Cobian L, Ganguly R, Sinnott JT. Barriers to hepatitis B vaccination in HIV
infected patients. New Orleans: Infectious Disease Society of America, 1993
35. Rushton TC, Ganguly R, Sinnott JT. Utilization of pneumococcal vaccine by internal medicine residents.
New Orleans: Infectious Disease Society of America, 1993
36. Bergen GA, Sanders LI, Yangco BG, Sinnott JT. Lack of asymptomatic mycobacterium avium
complex bacteremia in HIV infected patients with T-cell depletion. New Orleans: Interscience
Conference on Antimicrobial Agents and Chemotherapy, 1993
37. Cobian L, Spoto V, Sinnott JT, Ganguly R. Immunoprophylaxis against occupational risk of hepatitis
B infection. Chicago: American Academy of Allergy and Immunology, 1993
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
28
38. Mayer CA, Cobian L, Ganguly R, Sinnott JT, Villanueva L. Epidemiology and immunity to hepatitis
B in HIV infected patients [Poster]. Tampa: College of Medicine Faculty Research Day, 1993
39. Rushton T, Ganguly R, Sinnott JT. Utilization of pneumococcal vaccine by internal medicine residents.
New Orleans: Infectious Disease Society of America, 1993
40. Cancio M, Mayer C, Sinnott JT, Oehler R, Riter P, Holt DA. A simplified approach to controlling
methicillin-resistant Staphylococcus aureus with Hibiclens and mupirocin in a chronic ventilatory care facility.
Tampa: American College of Physicians, 1992
41. Spoto V, Greene J, Sandin R, Sinnott JT. Primary cutaneous filamentous fungal infections. Anaheim:
Interscience Conference on Antimicrobial Agents and Chemotherapy, 1992
42. Farrell C, Spoto V, Fuller S, Bergen G, Sinnott JT, Ganguly R. Hepatitis B vaccination among the
older health care providers. San Francisco: American Aging Association, 1992
43. Rushton TC, Ganguly R, Sinnott JT. Pneumococcal vaccine knowledge and attitude among internal
medicine residents. Atlanta: American Society for Microbiology, 1992
44. Cobian L, Mayer CA, Villanueva LP, Sinnott JT, Ganguly R. Hepatitis B vaccine acceptance in
HIV infected patients. Atlanta: American Society for Microbiology, 1992
45. Holt DA, Houston SH, Sinnott JT, Alexander LA, Oehler RL. The correlation of cadaveric blood
cultures with bone cultures. San Diego: American Association of Tissue Banks, 1992
46. Spoto VM, Greene JN, Sandin R, Hiemenz J, Sinnott JT. Lactobacillus casei: A newly described
cause of bacteremia in neutropenic patients [Poster]. Tampa: American College of Physicians, 1992
47. Mayer CA, Ganguly R, Sinnott JT: Hepatitis B: Immunity and Infection in HIV Infected Patients.
Naples: American Association of Osteopathic Internists, 1992
48. Spoto V, Cobian L, Shea JM, Sinnott JT, Ganguly R. Hepatitis B vaccination in elderly health care
providers. New Orleans: American Society for Microbiology, 1992
49. Holt DA, Houston SH, Sinnott JT, Alexander LA, Oehler RL. The correlation of cadaveric blood
cultures with bone cultures. Anaheim: Interscience Conference on Antimicrobial Agents and
Chemotherapy, 1992
50. Spoto V, Farrell C, Cobian L, Sinnott JT, Ganguly R. Hepatitis B in elderly health care providers
[Poster]. Tampa: University of South Florida College of Medicine Research Day, 1992
51. Spoto V, Cobian L, Shea JP, Sinnott JT, Ganguly R. Hepatitis B vaccination in elderly health care
providers. Baltimore: Society for Healthcare Epidemiology of America, 1992
52. Toney JF, Sinnott JT, Holt DA, Greene J, Seeley P. Chlamydia one dose treatment with
azithromycin. Baltimore: American Federation for Clinical Research, 1992
53. Kneer C, Sinnott JT, Shaw K. Percutaneous and mucocutaneous exposure of third year medical students
to blood and blood-tinged body fluids. Chicago: Interscience Conference on Antimicrobial Agents
and Chemotherapy, 1991
54. Cobian L, Sinnott JT, Shea JA, Ganguly R. Hepatitis B virus vaccine acceptance by the health care
professionals [Poster]. Tampa: American College of Physicians Scientific Meeting. Florida
Chapter, 1991
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
29
55. Ganguly R, Webster TB, Sinnott, JT, Chmel H. Immunization of the institutionalized elderly against
pneumococcal infection. Denver: American Aging Association and the American College of
Gerontology, 1991
56. Sinnott JT, Emmanuel PJ. Hepatitis C virus and bone transplantation. Atlanta: American
Federation for Clinical Research, 1991
57. Holt DA, Rosemurgy AS, Finney R, Cameron D, Ganguly R, Sinnott JT. An alternative central
access device in HIV-positive patients. Tampa: American College of Physicians, 1990
58. Sinnott JT, Holt DA. Nutritional perceptions of AIDS patients [Poster]. Tampa: American College
of Physicians Scientific Meeting, Florida Chapter, 1990
59. Frankel M, Sinnott JT, Gustke K. Prediction of postoperative infection in revision total hip surgery. New
Orleans: American Association for Orthopaedic Surgeons, 1990
60. Sinnott JT, Frankle M, Spiegel P, Cancio MR. Tuberculous osteomyelitis masked by concomitant
staphylococcal infection. Newport: American Orthopaedic Association, 1990
61. Emmanuel PJ, Sinnott JT. The recovery of bacteria from frozen bone biopsies. New Orleans: American
Federation for Clinical Research, 1990
62. Sinnott JT, Emmanuel PJ. Use of a bone protocol to evaluate pediatric osteomyelitis. New Orleans:
American Federation for Clinical Research, 1990
63. Ganguly R, Russell D, Sinnott JT, Fuller S, Cameron DJ. Nutritional practice and perception among
patients with HIV infection. Scarsdale: American College of Nutrition Annual Symposium, 1989
64. Sinnott JT, Riddle V, Cancio M. The role of sonification in processing bone cultures in patients with
osteomyelitis. Houston: Interscience Conference on Antimicrobial Agents and Chemotherapy,
1989
65. Sinnott JT, Himelright IM, Chlamydia species strain TWAR. Northbrook: Clinical Digest Series,
1989
66. Riddle V, Sinnott JT. The culture and sonication of osteomyelitic bone. Tampa: Student Research
Symposium, University of South Florida College of Medicine, 1989
67. Sinnott JT, Cullison JP, Sweeney MS, et al. Infectious complications associated with OKT3 use in
cardiac transplantation. Los Angeles: The International Society for Heart Transplantation, 1988
68. Sweeney MS, Macris MP, Frazier OH, Sinnott JT, et al. Treatment of advanced cardiac allograft
rejection. Boca Raton: Southern Thoracic Surgical Association, 1987
69. Sweeney MS, Sinnott JT, Cullison JP. The use of OKT3 for stubborn allograft rejection. An advance in
clinical immunotherapy. New Orleans: International Society for Heart Transplantation, 1987
70. Cardiac Transplant Team (Sinnott JT). Florida's first transplant program - The second year [Poster].
New Orleans: International Society for Heart Transplantation, 1987
71. Cardiac Transplant Team (Sinnott JT). Florida's first transplant program [Poster Presentation].
New York: International Society for Heart Transplantation, 1986
72. Yangco BG, Sinnott JT, McClelland JJ, Craig CP, Palumbo JM. Clinical study comparing
ceftazidime and cefamandole in lower respiratory tract infections. Las Vegas: Interscience Conference on
Antimicrobial Agents and Chemotherapy, 1983
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
30
73. Sinnott JT, Craig CP. Mouse liver macrophages and lipopolysaccharide neutralization. Birmingham:
The Journal of the Alabama Academy of Science, 1976
74. Sinnott JT. Effect of nitrous oxide on schedules of reinforcement. Augusta, Georgia: Psychological
Association, 1970
Newspaper Articles:
1.
Sinnott JT, Mundra L. Fever Serious Business [Letter]. Tampa Tribune, Nov 13, 2009
2.
Sinnott JT, Mundra L. Salary Focus Lacks Insight [Letter]. Tampa Tribune, Jun 28, 2009
3.
Sinnott JT, D‟Souza KR. Why India? [Editorial] Tampa Tribune, Mar 26, 2006
4.
Sinnott JT, Degryse A. Emerging threats [Invited Editorial]. Tampa Tribune, Sept 29, 2002
(Reprinted in part by USA Today, Apr 4-6, 2003)
5.
Sinnott JT, Degryse A. Man versus microbes [Invited Editorial]. Tampa Tribune, Mar 29, 2003.
(Co-published by USA Today, Yahoo, and Biz wire)
6.
Sinnott JT, Degryse A. Flu bug threatens public health [Invited Editorial]. Tampa Tribune, Jan
4, 2003
7.
Kerstyn A, Sinnott JT. Life and Death on your Own Terms [Book Review]. Tampa Tribune,
Oct 7, 2001
8.
Sinnott JT, Houston SH, Larkin JA. Commissioners acted against public interest on health
plan. Tampa Tribune, Jan 6, 2001
9.
Cancio M, Bartels L, Sinnott JT, Wright C. Culbreath has served well. Saint Petersburg Times,
2000
10. Cancio M, Sinnott JT, Bartels LJ, Wright C. Doctors prescribe antidote for Tampa General‟s
troubles. Tampa Tribune, 1999
11. Sinnott JT. The importance of hand washing. Tampa Tribune, Feb 1999
12. Sinnott JT. Glad for civilians in space. Tampa Tribune, Nov 4 1998
13. Sinnott JT. Bitter fruit [Letter]. Tampa Tribune, Dec 12, 1995
14. Sinnott JT, Houston SH. It's time for your vaccination update. Hillsborough Health Times,
Tampa, Florida, May 30, 1995
15. Sinnott JT. Chicken pox can be serious if adults become infected. La Gaceta, Tampa, Florida,
Apr 21, 1995
16. Sinnott JT. How much do you really know about the "flu"? La Gaceta, Tampa, Florida, Feb
10, 1995
Miscellaneous Creative Works:
1.
Public Service Announcement, Bioterrorism, in conjunction with Department of Health,
written, directed, and produced, 2009
2.
Sinnott JT. Dr‟s Travel Kit, Co-produced with USF Health Public Affairs, 2007. Link to video
podcasts: https://hscweb3.hsc.usf.edu/health/now/?p=401
3.
Sepsis Protocol for Rapid Diagnosis and Treatment © 2007 John Sinnott, MD
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
31
4.
Logan J, Sinnott JT. “Danger in the Flesh: Patients Infected with Life-threatening Bacteria
Must Race the Clock to Save Life and Limb.” ABC News, January 11, 2007.
http://abcnews.go.com/Health/story?id=2785223&page=1&CMP=OTC-RSSFeeds0312
(accessed April 16, 2010)
5.
Pneumonia Protocol for Rapid Diagnosis and Treatment © 2006 John Sinnott, MD
6.
Public Service Announcement, Herpes Infection, in conjunction with Department of Health,
written, directed, and produced, 2004
7.
Public Service Announcement, HIV, in conjunction with Department of Health, written,
directed, and produced, 2003
8.
Sinnott JT, Alexander E, Campbell M. Antibiogram: Percentage of strains susceptible to
antimicrobial agents listed. Tampa General Hospital. 2003 - present
9.
Sinnott JT. SARS protocol. Tampa General Hospital, March, 2003
10. Sinnott JT. RX: from your Chief of Staff. A time of change. Tampa General Healthcare,
Tampa, Florida, Spring, 1995
11. Sinnott JT. A proposal for rewarding teaching, implementation committee. University of
South Florida College of Medicine. Tampa, Florida, 1995
12. Sinnott JT. "The proper management of biomedical waste" [Videotape]. Agency for
Healthcare Administration. Tallahassee, Florida, 1995
13. Larkin J, Sinnott JT. HIV post exposure prophylaxis protocol. Bay Area Practitioners in
Infection Control, Tampa, Florida, 1994
14. Sinnott JT, Alexander LA. Florida statewide tissue serology testing standards. LifeLink Tissue
Bank, Tampa, Florida, 1994
15. Holt DA, Toney JF, Sinnott JT. Reviews of cephalosporins and aztreonam. Southern Medical
Association Dial Access Program, 1993
16. Sinnott JT. AIDS update [Video]. University of South Florida College of Medicine, Tampa,
Florida, 1993
17. Sinnott JT, Holt DA. Neural transplant tissue processing protocol. Tampa General Hospital,
Tampa, Florida, 1993
18. Sinnott JT, Holt DA. Fellows Manual. Division of Infectious Diseases. University of South
Florida College of Medicine, Tampa, Florida, 1992-1995. (Yearly editions)
19. Sinnott JT. Infectious diseases: one day at a time. [Student Education Manual]. University of
South Florida College of Medicine and Tampa General Hospital, Tampa, Florida, 1989
20. Rivers C, Palumbo JM, Sinnott JT. Exposure to: AIDS, hepatitis, tuberculosis, what to do.
Tampa General Hospital Employee Health Services Guide, 1989
21. Sinnott JT, Immunosuppressed lung biopsy protocol. Tampa General Hospital, Tampa,
Florida, 1989
22. Sinnott JT, Nixon L, Hill DA, et al. The American Medical Association and the American
Medical Student Association Adolescent AIDS Educational Program. University of South
Florida College of Medicine, AIDS curriculum for public schools, Outreach program for
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
32
College of Medicine student body approved by Hillsborough County Board of Public
Instruction, Tampa, Florida, 1988
23. Sinnott JT, Alexander LA. Bacteriology for the tissue procurement laboratory. LifeLink of
Tissue Bank, Tampa, Florida, 1988
24. Sinnott JT, Rasp J, Arnold J. Facts on the HIV antibody test. Tampa General Hospital Patient
Education Series, Tampa, Florida, 1988
25. Sinnott JT. Treatment of urinary tract infections with single-dose antimicrobials. South Med
Assoc Dial Access Program, 1987
26. Sinnott JT. "How Infection Control Prepares for Joint Commission for Accreditation of
Hospital" (Videotape). Joint Commission on Accreditation of Hospitals National
Teleconference. Tampa, Florida, 1987
27. Sinnott JT. Bone protocol. Tampa General Hospital and Shriner's Hospital for Crippled
Children, Tampa, 1987
Non-Published Creative Works:
1.
Sinnott JT. Professionalism in Infectious Diseases. Sept 19, 2009. Podcast found at:
www.idpodcasts.net
2.
Sinnott JT. Q & A: Dr. John Sinnott on H1N1 (Swine) Flu [Video series], in conjunction with
USF Health. Oct 2009. Found at: http//hscweb3.hsc.usf.edu/health/now/?p=5568
3.
Sinnott JT, Thompson P. Guidance for Healthcare Workers on Swine Flu [Video series]. Oct
2009, found at: http://www.youtube.com/watch?v=xiscxJBqYKs
4.
20 Questions: John T. Sinnott, MD, FACP, Featured on the Student Doctor Network. Feb 13,
2008, found at: http://www.studentdoctor.net/2008/02/cover-your-mouth-when-you-sneeze/
5.
Sinnott JT. Travel Medicine for the Clinician. Jul 11, 2007. Podcast found at
www.idpodcasts.net.
Research:
Industry Grants:
1. Houston SH, Sinnott JT. The effects of formulary conversion from ceftazidime to cefepime on
the in vitro sensitivities of Pseudomonas serginosa, Enterobacter cloacae, and Klebsiella pneumoniae to
selected antibiotics. ($20,000) (90% effort), Enzon, 1999–2000
2. Houston SH, Larkin JA, Sinnott JT, Montero JA, Cancio MR, Ubillos S, Mayer C, Busciglio L.
Open study of Synercid (quinupristin/dalfopristin) for emergency use, (20% effort). RhonePoulenc Rorer, 1999–2000
3. Houston SH, Sinnott JT, Larkin JA, Montero JA, et al. Linezolid for the Treatment of
Vancomycin-Resistant Enterococcal Infections: A Double-Blind Trial. (20% effort). Pharmacia,
1999
4. Sinnott JT, Larkin JA, Houston SH: Antimicrobial Sensitivity to Respiratory Tract Pathogens,
(20% effort). Bristol-Myers Squibb, 1999
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
33
5. Sinnott JT: Antimicrobial Activity and Spectrum Investigation of Eight Broad- Spectrum BLactam Drugs: A 1997 Surveillance Trail in 102 Medical Centers in the United States, (20%
effort). Bristol Meyers Squibb, 1998
6. Sinnott JT: The National H pylori Screening Initiative, (50% effort). Abbott Laboratories, 1997
7. Larkin JA, Sinnott JT, et al. Surveillance of resistant gram-positive bacteremia in the U.S.
National Nosocomial Surveillance Group, (30% effort). The Clinical Pharmacokinetics
Laboratory, 1996. ($3,000)
8. Larkin JA, Nadler J, Sinnott JT, et al. Multi-center study to evaluate Nystatin in non-neutropic
patients with Candidemia, (33% effort). Aronex, 1996. ($62,500)
9. Sinnott JT, Holt DA, Houston SH, Cancio M, Larkin JA, et al. A randomized, double blinded,
placebo controlled trial of the presumptive use of fluconazole in febrile intensive care unit
patients at risk for fungal infections, (30% effort). Pfizer, 1996. ($60,000)
10. Larkin JA, Holt DA, Houston SH, Sinnott JT. In vitro sensitivity of HIV claves to ritonavir
(ABT-538). (50% effort). Abbott Laboratories, 1996 ($10,000)
11. Sinnott JT, et al: Fluconazole for empiric Treatment of Candidiasis, (50% effort). Pfizer
Pharmaceutical, 1996
12. Lyman G, Sinnott JT, et al. The safety and efficacy of rhGM-CSF when administered to
patients with neutropenia. Sandoz, 1995, (5% effort)
13. Larkin JA, Sinnott JT, Toney J. HIV Cost and utilization study, The Agency for Health Care
Policy (AHCPR) and Research, (33% effort). Rand, 1995 – present. ($6,000)
14. Sinnott JT: Prevalence of Important Pathogens and Antimicrobial Activity of Parenteral Drugs
at Numerous Medical Center in the United States: Study on the Threat of Emerging Resistances:
Real or Perceived? (10% Effort). 1994
15. Sinnott JT: Fluoroquinolone Resistance Surveillance Group in U.S. Surveillance Study of
Parenteral Antimicrobial Agents as Empiric Therapy of Pathogens, (10% effort), Elsevier, 1994
16. Toney JF, Sinnott JT, Holt DA, Greene JN: Safety Tolerance, Efficacy Study of
Piperacillin/Tazobactam plus Tobramycin in Sepsis (20% effort). American Cyanamid, 1994
17. Toney JF, Sinnott JT, Holt DA, Greene JN: A Double-Blinded, Randomized, Multicenter,
Comparative Study of Cefodizime versus Ceftriaxone in Pneumonia (20% effort). Upjohn
Pharmaceuticals, 1994
18. Toney JF, Greene JN, Sinnott JT, Holt DA: Pentoxifylline versus Placebo for the Prevention of
Amphotericin Nephrotoxicity, (20% effort). Hoechst Pharmaceuticals, 1994
19. Toney JF, Sinnott JT, Holt DA, Greene JN: Teicoplanin vs. Ceftriaxone in Skin Infections,
(20% effort). Merrell Dow Pharmaceuticals, 1992
20. Greene JN, Sinnott JT, Holt DA, Toney JF: Pentoxifylline vs. Placebo in the Prophylaxis of
Amphotericin B-induced Nephrotoxicity (20% effort). Hoechst Pharmaceuticals, 1992
21. Toney JF, Sinnott JT, Holt DA, Greene JN: Comparison of Cefaclor vs. Ofloxacin in
Pneumonia / Bronchitis (20% effort). Ortho Pharmaceuticals, 1992
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
34
22. Toney JF, Sinnott JT, Holt DA, Greene JN: Piperacillin / Tazobactam and Tobramycin vs.
Imipenem and Tobramycin in Septicemia (10% effort). American Cyanamid, 1992
23. Toney JF, Sinnott JT, Holt DA, Greene JN: Ceftriaxone vs. Cefodizime in the Treatment of
Pneumonia (25% effort). Fujisawa Pharmaceuticals, 1992
24. Toney JF, Sinnott JT, Holt DA, Greene JN: Temafloxacin vs. Imipenem in the Treatment of
Skin Infections (25% effort). Abbott Laboratories, 1992
25. Toney JF, Sinnott JT, Holt DA, Greene JN: Ampicillin / Sulbactam in the Treatment of
Urinary Tract Infections (25% effort). Roerig Pharmaceuticals, 1992
26. Sinnott JT, Holt DA, Hurst JM, Greene JN, Rosemurgy AT: Randomized Trial of a Chimeric
Anti-Endotoxin Monoclonal Antibody (33% effort). Centocor Corporation, 1991
27. Sinnott JT, Greene JN. Anti-endotoxin antibody in the treatment of patients with suspected
gram-negative bacteremia and endotoxemia. Pfizer, 1987–1992, ($20,000)
28. Yangco BG, Sinnott JT, Holder CD, Toney JF, Cullison JP. Comparison of intravenous
cefmetazole and cefoxitin in the treatment of urinary tract infections. (20% effort) Upjohn, 1987
29. Yangco BG, Sinnott JT, Holder CD, Toney JF, Cullison JP. Ceftazidime L-Arginine in the
treatment of bacterial infections of the skin and blood. (20% effort) Glaxo, 1987
30. Yangco BG, Sinnott JT, Toney JF, Cullison JP, Cancio MR: BMY-28100 Versus Cefaclor in
the Treatment of Urinary Tract Infections (20% effort). Bristol-Myers Pharmaceuticals, 1987
31. Yangco BG, Sinnott JT, Toney JF, Cullison JP, Cancio MR: BMY-28142 in the Treatment of
Urinary Tract, Lower Respiratory Tract and Skin, Skin Structures Infections (20% effort).
Bristol-Myers Pharmaceuticals, 1987
32. Yangco BG, Sinnott JT, Toney JF, Cullison JP, Cancio MR: CI-919 (Enoxacin) Versus
Carbenicillin in Prostatitis (20% effort). Ortho Pharmaceuticals, 1987
33. Yangco BG, Sinnott JT, Toney JF, Cullison JP, Cancio MR: BMY-28100 versus Cefaclor in the
Treatment of Skin and Skin Structure Infections (20% effort). Bristol-Myers Pharmaceuticals,
1987
34. Spiegel PG, Sinnott JT, Belsole RJ, et. al., Protocol to Determine and Compare the Efficacy and
Tolerance of Gentamicin from Beads and Surgical Wire (Septopal) and Conventional Antibiotic
Therapy for the Treatment of Chronic Osteomyelitis (25% effort). Richards Pharmaceuticals,
1986
35. Yangco BG, Sinnott JT, Holder CD, Toney JF, Cullison JP: Ceftazidime vs. Ceftazidime LArginine in Bacterial Infections of the Skin, Skin Structures and Blood (20% effort). Glaxo
Pharmaceuticals, 1986
36. Yangco BG, Sinnott JT, Holder CD, Toney JF, Cullison JP: Efficacy, Safety, and Tolerability
of Intramuscularly Administered Imipenem/Cilastatin (20% effort). Merck Pharmaceuticals,
1986
37. Yangco BG, Sinnott JT, Holder CD, Toney JF, Cullison JP: Ofloxacin vs. Amoxicillin in the
Treatment of Upper Respiratory Tract Infections (20% effort). Ortho Pharmaceuticals, 1986
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
35
38. Yangco BG, Sinnott JT, Holder CD, Toney JF, Cullison JP: Comparison of the Safety and
Efficacy of Ceftazidime vs. an Anti-Pseudomonal Penicillin and an Aminoglycoside in the
Treatment of Hospital-Acquired Pneumonia (20% effort). SmithKline Pharmaceuticals, 1986
39. Yangco BG, Sinnott JT, Holder CD, Toney JF, Cullison JP: Cefuroxime versus Augmentin in
the Treatment of Lower Respiratory Tract Infections (20% effort). Glaxo Pharmaceuticals,
1986
40. Yangco BG, Sinnott JT, Holder CD, Toney JF, Cullison JP: Comparison of Cefmetazole and
Cefoxitin in the Treatment of Urinary Tract Infections (20% effort). Upjohn Pharmaceuticals,
1986
41. Yangco BG, Sinnott JT, Holder CD, Toney JF: An Open Non-comparative Trial of Enoxacin
in Patients with Lower Respiratory Infections (25% effort). Miles Pharmaceuticals, 1985
42. Yangco BG, Sinnott JT, Craig CP, Holder CD, Toney JF: A Comparative Multi-Center
Evaluation of Cefadroxil and Amoxicillin Therapy in the Treatment of Uncomplicated Urinary
Tract Infections (20% effort). Bristol-Myers Pharmaceuticals, 1985
43. Yangco BG, Sinnott JT, Craig CP, Holder CD, Toney JF: A Multicenter Randomized Blinded
Study Comparing Intravenously Administered Cefpiramide and Ceftizoxime (Cefizox) in the
Treatment of Hospitalized Patients with Infections Caused by Susceptible Aerobic and
Anaerobic Bacteria (20% effort). Wyeth Pharmaceuticals, 1985
44. Yangco BG, Craig CP, Sinnott JT, Holder CD, Toney JF: A Multicenter Open Study of the
Efficacy, Safety and Tolerance of Primaxin in the Therapy of Presumed or Proven Bacterial
Infections (20% effort). Merck Pharmaceuticals, 1985
45. Yangco BG, Sinnott JT, Holder CD, Toney JF, Cullison JP: Comparison of Cefmetazole and
Cefoxitin in the Treatment of Pneumonia (20% effort). Upjohn Pharmaceuticals, 1985
46. Yangco BG, Sinnott JT, Holder CD, Toney JF, Cullison JP: A Comparative Study of the Safety
and Efficacy of Ceftazidime vs. Tobramycin/Piperacillin in the Treatment of Hospital-Acquired
Pneumonia (20% effort). Glaxo Pharmaceuticals, 1985
47. Yangco BG, Sinnott JT, Holder CD, Toney JF: A Multicenter Comparison of Apalcillin and
Piperacillin in Combination with Gentamicin in the Treatment of Hospitalized Patients with
Fever and Granulocytopenia (25% effort). Wyeth Pharmaceuticals, 1985
48. Yangco BG, Sinnott JT, Holder CD, Toney JF: A Randomized, Blinded Study Comparing
Cefpiramide and Cefoperazone in the Treatment of Hospitalized Patients (25% effort). Wyeth
Pharmaceuticals. 1985
49. Yangco BG, Sinnott JT, Holder CD, Toney JF: A Comparative Multicenter Evaluation of
Cefadroxil and Amoxicillin Therapy in the Treatment of Uncomplicated Urinary Tract
Infections (25% effort). Bristol Myers Pharmaceuticals, 1985
50. Holder CD, Craig CP, Yangco BG, Sinnott JT, Toney JF: Emergency Treatment of Pneumocystis
carinii Pneumonia in Immunoincompetent Patients with Difluoromethylornithine (20% effort).
Merrell Dow Pharmaceuticals, 1985
51. Yangco BG, Sinnott JT, Craig CP, Holder CD, Toney JF: Early Phase II Efficacy and Safety of
Teicoplanin in Patients with Gram Positive Infections (20% effort). Merrell Dow
Pharmaceuticals, 1985
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
36
52. Yangco BG, Craig CP, Sinnott JT, Holder CD, Toney JF: A Multicenter Open Study of the
Efficacy, Safety, and Tolerance of Primaxin in the Therapy of Bacterial Infection (20% effort).
Merck, Sharpe and Dohme Pharmaceuticals, 1985
53. Yangco BG, Craig CP, Sinnott JT, Holder CD, Toney JF: Multicenter Randomized, Blinded
Study Comparing Cefpiramide and Ceftizoxime in the Treatment of Hospitalized Patients (20%
effort). Wyeth Pharmaceuticals, 1985
54. Yangco BG, Sinnott JT, Toney JF, Holder CD: Cefpiramide versus Ceftizoxime in Bacteremic
Patients (25% effort). Wyeth Pharmaceuticals, 1985
55. Sinnott JT, Yangco BG, Craig CP, Holder CD, Toney JF: Cefoperazone Sodium in the
Treatment of Bone and Joint Infections (20% effort). Roerig Pharmaceuticals, 1985
56. Yangco BG, Sinnott JT, Holder CD, Toney JF: Ceftazidime versus Ceftazidime L-arginine in
Bacterial Infections of the Skin, Skin Structures and Blood (25% effort). Glaxo Pharmaceuticals,
1984
57. Yangco, BG, Sinnott JT, Craig CP, Holder C, Norris D: Cefbuperazone in Lower Respiratory
Tract, Infection (20% effort). Bristol Pharmaceuticals, 1984
58. Yangco BG, Craig CP, Sinnott JT, Holder C, Norris D: Cefuroxime Axetil versus Cefaclor in
the Treatment of Infections of Skin or Skin Structure (20% effort). Glaxo Pharmaceuticals,
1984
59. Yangco BG, Craig CP, Sinnott JT, Holder C, Norris D: Pseudomonas aeruginosa Infections
with:Cefsulodin or Piperacillin (20% effort). Abbott Laboratories, 1984
60. Yangco BG, Sinnott JT, Craig CP, Holder C, Norris D: Open Multicenter Study of Cefpiramide
in Hospitalized Patients (20% effort). Wyeth Pharmaceuticals, 1983
61. Yangco BG, Craig CP, Sinnott JT, Norris DG: U-63196E versus Cefotaxime in the Treatment
of Urinary Tract Infections (25% effort). Upjohn Pharmaceuticals, 1983
62. Yangco BG, Craig CP, Spiegel PG, Sinnott JT, McClelland JJ: Cefuroxime versus Cefazolin in
of Bone and Joint Infections (20% effort). Glaxo Pharmaceuticals, 1983
63. Yangco BG, Craig CP, Sinnott JT, McClelland JJ: Cefotetan versus Moxalactam in the
Treatment of Hospitalized Patients with Pneumonia (25% effort). Stuart Pharmaceuticals, 1983
64. Yangco BG, Craig CP, Sinnott JT, McClelland JJ: Cefoxitin versus Two Dosage Regimens of
Cefotetan in Urinary Tract Infections (20% effort). Stuart Pharmaceuticals, 1983
65. Yangco BG, Craig CP, Sinnott JT, Holder CD, Toney JF: Cefpimizole vs. Cefoperazone in
Lower Respiratory Tract Infection (20% effort). Upjohn Pharmaceuticals, 1983
66. Yangco BG, Sinnott JT, Craig CP: Addendum to: "A Multicenter Randomized Study to
Compare the Efficacy and Safety of Ceftazidime and Cefamandole in the Treatment of Lower
Respiratory Infections" to include treatment of skin and skin structure infections with or without
bacteremia (33% effort). Glaxo Pharmaceuticals, 1982
67. Yangco BG, Craig CP, Sinnott JT, McClelland JJ: Ceftizoxime versus Moxalactam or
Cefotaxime for Pneumonia in Patients at Risk (25% effort). SmithKline Pharmaceuticals, 1982
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
37
68. Yangco BG, Craig CP, Sinnott JT, McClelland JJ: A Comparative Study of Intravenous
Cefotetan vs. Cefoxitin in the Treatment of Hospitalized Patients with Urinary Tract Infections
(25% effort). Stuart Pharmaceuticals, 1982
69. Yangco BG, Sinnott JT, Craig CP: A Randomized Study to Comparing Ceftazidime and
Cefamandole in the Treatment of Lower Respiratory Tract Infections (30% effort). Glaxo
Pharmaceuticals, 1982
70. Yangco BG, Sinnott JT, Craig CP: Controlled Study Comparing Cefonicid with Cefazolin in
Urinary Tract Infections (30% effort). SmithKline Pharmaceuticals, 1981
Grants (Federal, State, and Other):
1. Sinnott JT, Knox M, Beal J, et al. Hepatitis C Treatment Expansion Initiative Evaluation and
Technical Assistance Center. Health Resources and Services Administration (HRSA), 2010 –
2014. ($1.6 M)
2. Sinnott JT, Menezes L: Training Program for Physician Leaders, Gansu Provincial Health
Department, Gansu Province, Lanzhou, China, 2010. ($87,000)
3. Toney JF, Schmitt K, Sinnott JT: Florida STD/HIV Prevention Training Center (PTC) –
region IV STD/HIV Prevention Training Center (Program Announcement 00031). Centers for
Disease Control and Prevention, (5% effort), 2000 – 2005. ($268,000 yearly, 5 year renewal)
4. Sinnott JT, Menezes L, Naik E, & Wills T: Training Program on Disaster management,
Emerging Infections and Trauma Care for Policy Planners and Physicians in resource limited
settings. Government of Maharashtra, India. 05/05-7/05. ($55,200)
5. Sinnott JT, Menezes L: Impact of Methicillin Resistant Staphylococcus aureus (MRSA) on the
Tampa Bay Community. Pfizer. TGH Foundation. 01/05. ($60,000)
6. Amuso P & Sinnott JT: State Health Laboratory Management. Florida Department of Health,
(10% effort), 2004 – 2007. ($278,901)
7. Sinnott JT, Martin R: Laboratory Quick Reference Guide for Category A Biological Agents.
Florida Department of Health, (5% effort), 2004. ($14,280)
8. Sinnott JT: Florida Infectious Disease Institute. Florida Department of Health, 2003 – present.
($1,000,000)
9. Sinnott JT, Montero JA: STD training development grant. Pfizer, (33% effort), 1999 – 2001.
($75,000 yearly)
10. Saba H, Larkin J, Sinnott JT, Gompf S: Region IV South Ryan White Care Act Title III,
Hemophilia of Georgia (33% effort), 1999 – 2005. ($124,614)
11. Emmanuel P, Larkin J, Sinnott J, Gompf S: Ryan White Care Act Title I, Primary Care for
Women, Infants, and Children (33% effort). 1999 – 2001. ($27,000)
12. Sinnott JT: Infection Control Grant. The Tampa General Hospital Auxiliary, (100% effort),
1998. ($3,000)
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
38
13. Larkin JA, Sinnott JT, Holt DA: Housing and Urban Development Grant for Multi-purpose
facility for AIDS/HIV related services. Hillsborough County Public Health Unit, (50% effort),
1996. ($1,000,000)
14. Larkin JA, Shashy RG, Sinnott JT: Sexually Transmitted Diseases Faculty Expansion Program
Grant (Announcement # 616). Centers for Disease Control and Prevention/Department of
Health and Human Services, (33% effort), 1996. ($400,000)
15. Larkin JA, Sinnott JT, Toney J: HIV Cost and utilization study. The Agency for Health Care
Policy (AHCPR) and Research, Rand, (30% effort), 1995 – 1998. ($6,000 yearly)
16. Sinnott JT, Houston SH, Holt DA: Primary Care Approach to HIV Management, Ryan White
Title IV, Grant DHHS-BRH Human Rehabilitative Services, (40% effort), 1995 – 1996.
($12,000)
17. Sinnott JT: Medical Student Medical Research Grant, Tampa General Healthcare Foundation,
Tampa, Florida, 1995. ($1000)
18. Sinnott JT, Holt DA, Cunningham B, Houston SH: Multidisciplinary Team Enhanced AIDS
Management Models (TEAM). Ryan White Title IX, Grant DHHS-BRH# 890024-01-0, Human
Rehabilitative Services, (40% effort), 1993 – 1998. ($14,000)
19. Sinnott JT, Holt DA, Houston SH, Sanders L: The Medical Student History and Physical
Examination of the AIDS Patient: Focus on Attitude and Techniques. Florida AIDS Education
Training Network, DHHS-BHP No.1 D35 PE 00101-02, Subcontract A, (25% effort), 1993.
($5,000)
20. Knox M, Sinnott JT: Florida AIDS Education and Training Network, DHHS-BHP No. 1 D35
PE00101-02 (subcontract 10% effort), 1992 – 2004. ($12,000)
21. Holt DA, Sinnott JT, Cancio MR: HIV Health Care Cost in Hospitalized Patients. United
States Public Health Service, Grant #R067, Westat Research, (15% effort), 1991 –1992.
($10,000)
Contracts (Divisional, Negotiated):
1. Sinnott JT, Holt D: Hillsborough County Health Department Management Contract. Florida
Department of Health, 1996 – present ($604,500 yearly)
2. Sinnott JT: Laboratory Management Contract. Lifelink Bone and Tissue Bank. 2003 – 2008
($24,000 yearly)
3. Sinnott JT: Infection Control Contract. Shriner‟s Children‟s Hospital. 2003 – present ($13,800
yearly)
4. Haight D, Sinnott JT: Polk County Health Department Management Contract. Florida
Department of Health, 1997 – present ($162,391 yearly)
5. Sinnott JT: Infectious Disease Case Management. Tampa General Hospital, 1996 – present
($30,000 yearly)
6. Sinnott JT: Employee Health Medical Director. Tampa General Hospital, 1985 – present
($80,000 yearly)
6/24/2011
CURRICULUM VITAE
John T. Sinnott, MD, FACP
39
Miscellaneous Scholarly Activities:
Faculty, Florida/Caribbean AIDS Education and Training Center, 2002-present
Co-Sponsor, Yale University Drinking Water Symposium, New Haven, 2009
American College of Physicians, Speaker - Bioterrorism Speakers Bureau, 2007-2008
Keynote Speaker, Conversations with Influence, Tampa Bay Performing Arts Center, Leadership
Tampa, 2006
Keynote Speaker, University of South Florida Mini-Med School, Tampa Bay Performing Arts
Center, 2005
Keynote Speaker, State of Florida Epidemiologist Update, Sanford, 2004
Keynote Speaker, 3rd Annual Infection: Maximizing the Probability of Positive Outcomes Meeting, US
Micron, Frisco, 2004
Keynote Speaker, Florida Infectious Disease Society, Longboat Key, 2002
Invited Lecturer, Florida Infectious Disease Society, Jacksonville, 1995
Invited Lecturer, American College of Physicians, Florida Scientific Meeting, Orlando, 1993
Question Author, American Board of Internal Medicine, Re-certification examination,
Philadelphia, 1993 –1996
Consultant, Human Fetal Nigral Transplant Program, University of South Florida, Tampa
General Hospital, Tampa, 1993 – 2001
Instructor, American College of Physicians, Medical Knowledge Program, Orlando, 1993.
Invited Lecturer, Florida Medical Association, Palm Beach, 1993 –1994
Course Director, Chronic Fatigue Syndrome Update, Sarasota, 1992
Instructor, Internal Medicine Review Course, American College of Physicians, Lake Buena Vista,
1991
Judge, International Science and Engineering Student Competition, Intel, Orlando, 1991
Moderator, Infectious Diseases II. Southern Society, American Federation for Clinical Research,
New Orleans, 1990
Advisor and Co-Founder, Adolescent AIDS Education Program. The American Medical
Association, University of South Florida College of Medicine, Tampa, Florida, 1987 – 1996
Consultant, Hillsborough County: President's National Committee on AIDS Site Visit, Tampa,
1987
Instructor, Medical Knowledge Self-Assessment Program. American College of Physicians,
Orlando, 1987
Invited Lecturer, Paraprofessional Counseling Service, University of South Florida, Tampa, 1984
–1986
6/24/2011